University of Kentucky

UKnowledge
Theses and Dissertations--Microbiology,
Immunology, and Molecular Genetics

Microbiology, Immunology, and Molecular
Genetics

2020

Elucidating the Complex Signaling Events Driving Intestinal Stem
Cell Plasticity Following Injury
Evan Lynch
University of Kentucky, evan.lynch@uky.edu
Digital Object Identifier: https://doi.org/10.13023/etd.2020.196

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Lynch, Evan, "Elucidating the Complex Signaling Events Driving Intestinal Stem Cell Plasticity Following
Injury" (2020). Theses and Dissertations--Microbiology, Immunology, and Molecular Genetics. 23.
https://uknowledge.uky.edu/microbio_etds/23

This Doctoral Dissertation is brought to you for free and open access by the Microbiology, Immunology, and
Molecular Genetics at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Microbiology,
Immunology, and Molecular Genetics by an authorized administrator of UKnowledge. For more information, please
contact UKnowledge@lsv.uky.edu.

STUDENT AGREEMENT:
I represent that my thesis or dissertation and abstract are my original work. Proper attribution
has been given to all outside sources. I understand that I am solely responsible for obtaining
any needed copyright permissions. I have obtained needed written permission statement(s)
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing
electronic distribution (if such use is not permitted by the fair use doctrine) which will be
submitted to UKnowledge as Additional File.
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and
royalty-free license to archive and make accessible my work in whole or in part in all forms of
media, now or hereafter known. I agree that the document mentioned above may be made
available immediately for worldwide access unless an embargo applies.
I retain all other ownership rights to the copyright of my work. I also retain the right to use in
future works (such as articles or books) all or part of my work. I understand that I am free to
register the copyright to my work.
REVIEW, APPROVAL AND ACCEPTANCE
The document mentioned above has been reviewed and accepted by the student’s advisor, on
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of
the program; we verify that this is the final, approved version of the student’s thesis including all
changes required by the advisory committee. The undersigned agree to abide by the statements
above.
Evan Lynch, Student
Dr. Terrence Barrett, Major Professor
Dr. Carol Pickett, Director of Graduate Studies

ELUCIDATING THE COMPLEX SIGNALING EVENTS
DRIVING INTESTINAL STEM CELL PLASTICITY FOLLOWING INJURY

__________________________________
A DISSERTATION
__________________________________
A dissertation submitted in partial fulfillment of
the requirements for the degree of Doctor of Philosophy
in the College of Medicine at the University of Kentucky
Author: Evan Brady Lynch
Lexington, KY
Director: Terrence A. Barrett, MD
Professor of Microbiology, Immunology and Molecular Genetics
April 15, 2020
Copyright © Evan Lynch 2020

ABSTRACT OF DISSERTATION

ELUCIDATING THE COMPLEX SIGNALING EVENTS DRIVING INTESTINAL STEM
CELL PLASTICITY FOLLOWING INJURY
Signaling events governing intestinal stem cell (ISC) homeostasis maintain the
delicate balance of active self-renewal and passive differentiation to replenish intestinal
epithelial cells (IEC) every 3-5 days. However, under certain contexts, ISC function is
irreversibly compromised—requiring committed IEC lineages to dedifferentiate and
regain “stemness”. In the current studies, we examine the signaling events driving
epithelial cell responses to injury to expose pathologic failures in the healing response.
Our specific goal is to tease out the cellular contexts that promote dedifferentiation to
design effective therapeutics for disease conditions compromising ISC function.
First, we generated a novel transgenic animal using the epithelial-specific Villin
promoter to constitutively ablate the critical negative regulator in the Phosphotidylinositol 3 Kinase (PI3K) signaling pathway, p85α, in IECs. At baseline, removal of p85α
led to increased activation of PI3K/Akt, as seen through elevations in phosphorylated
PTEN, Akt, and GSK3β. The consequence of the persistent activation was a shifting of
cells out of the stem cell niche, into more differentiated the proliferative progenitor pool,
as seen by a decrease in Lgr5+ cells per crypt and an increase in Axin2+ transcripts by in
situ hybridization. Further investigations revealed PI3K activation led to a bolstered
secretory lineage, increased total number and size of Paneth cells within the crypt
through reduced Notch signaling. Subsequent studies mechanistically clarify
mitochondrial bioenergentics in p85-deficient epithelial cells demonstrate enhanced
State III respiration to drive production of ROS. ROS activates p38-MAPK to mount
observed differentiation pressure. Using whole-body irradiation to target ISCs, we
revealed that p85-deficient crypts underwent restitution at a faster pace than their control
counterparts. The consequence of the enhanced regeneration was an increased
organism survival after lethal irradiation. Transcript flux revealed that p85-deficient crypts
increased Wnt and PI3K signaling targets, specifically Lgr5, Axin2 and Survivin earlier in
the regenerative process, suggesting the increased secretory progenitor pool could
enact dedifferentiation mechanisms to replenish ISCs. Using human samples of
radiation-induced intestinal injury, we demonstrate the requirement of Wnt-target
Survivin protein expression in IEC survival, suggesting a conserved mechanism and
possible avenue for future therapeutic intervention.
Next, using isolated crypt epithelial cells from patients with inflammatory bowel
disease (IBD), we establish that steroid-treated (prednisone) IBD patients harbor

aberrant Wnt/β-catenin and NFκB signaling in IECs despite clinical improvement. At the
molecular level, human IECs had significantly blunted cytosolic accumulation of Axin2
protein and subsequently decreased nuclear localization of downstream transcriptional
activator, p-β-cateninSer552. Using a validated murine model of IBD, Dextran Sodium
Sulfate-induced colitis (DSS colitis), we appreciated conserved blunting of inflammationinduced Wnt activation following dexamethasone administration. Studies in isolated
murine ISC cultures revealed that the blunting of Wnt activation occurred in the absence
of inflammatory stimulus—suggesting steroids directly affect ISC activation by interfering
with β-catenin transcriptional activity. By tracking β-catenin-directed TCF/LEF
transcriptional activity with a stably-transfected luciferase construct, we identified the
signaling disruption occurred downstream of the β-catenin destruction complex, and
resulted in limited ISC activation and mobilization in response to injury. Appropriately,
primary ISC cultures from mice demonstrated that at high doses, steroid therapy
inappropriately limits ISC activation sufficient Wnt ligands in culture. This leads to a
depleted ISC pool and preventing mucosal restitution after injury.
KEYWORDS: Wnt, Intestinal Stem Cell, Inflammatory Bowel Disease, Metabolism,
Radiation, Plasticity
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Chapter 1: Thesis Introduction:
Dynamic Regulation of Crypt Ultrastructure:
The intestinal epithelial cell (IEC) performs multiple critical roles to support
organism health and vitality. However, IECs sit juxtaposed between two uniquely
treacherous environments—the intestinal lumen, which houses a robust microbial
constituency, and the lamina propria rich in immune and mesenchymal cell components
critical to the health and self renewal capacity of the epithelial compartment. This
densely interconnected network creates a sometimes-unforgiving environment for
epithelial cell survival. To meet the challenge, the entire epithelial cell compartment
undergoes complete renewal every 3-5 days [1], and thus, relies heavily on the wellconditioned activity of the crypt-villus unit’s stem cells. Intestinal stem cells (ISCs),
residing at the base of the crypt, establish the cellular hierarchy of the crypt and drive
this orderly rejuvenation of all IEC lineage types. These ISCs have been roughlyseparated into two classes. First, high-cycling, Lgr5+ stem cells [2] drive the majority of
daily self-renewal activities under homeostatic conditions. “Reserve” or quiescent stem
cells (q-ISC), marked by distinct cellular signatures [3-7], interconvert into high-cycling
ISCs in instances of frank tissue damage. In this regard, crypt regeneration is a
predictably reproducible phenomenon—the varying susceptibility of high-cycling and qISCs to different mechanisms of injury provides a failsafe to insure organ system survival
under multiple types of distinct cellular stresses.
Importantly, ISCs maintain several key characteristics that distinguish them from
stem cells of other organ systems. While other stem cells experience a programmed
asymmetric division into a “new” stem cell and “differentiated daughter” cell, ISCs do not
seem to be constrained to this paradigm [8]. Instead, ISCs experience neutral
competition, where each daughter cell has the potential to become a new stem cell. This
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mechanism insures both a consistent number of stem cells within the niche (12-15 Lgr5+
stem cells) and efficiently replacement of damage stems [9]. The latter point becomes
salient in the response to tissue injury. In the absence of large numbers of ISCs, how
might the crypt unit undergo functional regeneration without its full compliment of stems
[10]? To this end, researchers and clinicians have identified contexts that invariably
compromise the activity of both essential stem populations, creating a significant gap in
stem cell-mediated regenerative paradigms. Under these conditions, previous
investigators have shown that differentiated IECs can undergo de-differentiation to
replenish the depleted stem compartment [11-14]. A pictoral representation of the
highlights of this section, namely crypt hierarchy and response after ISC compromise is
outlined in Figure 1.1[15], but many questions remain. Previous works have exposed the
immutable truth that epithelial “stemness” is not an inherent property of stem cells, and
thus can be re-acquired readily by multiple cell types [11]. To the authors of this
publication, the fact that multiple cell types can undergo the same dedifferentiation
pressure to replenish damaged or absent ISCs undermines the necessity of discovering
the cellular identity of the participants. Rather, the more clinically-revelant important area
of investigation is the context driving dedifferentiation itself. Our findings underpin a
critical gap in the understanding of stem cell plasticity—namely, the thorough
understanding of the contexts initiating cellular dedifferentiation in response to stem cell
compromise.
Purpose Statement: The current work considers two specific injury contexts,
radiation injury to ISCs and pharmacologic intervention preventing the appropriate
activation of ISCs in response to inflammatory injury. We argue the work contained
herein, endeavoring to define context-specific dedifferentiation, addresses a more
clinically-relevant question: how can clinicians optimize therapeutic interventions to
promote effective and efficient crypt restitution in the absence of a highly-active stem cell
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compartment? Our ultimate goal is to elucidate a mechanism that allows for committed
IECs to re-acquire inherent “stemness” to enhance regenerative responses to crypt
injury. The elaboration of these critical signaling drivers represents a novel treatment
avenue to address a multitude of complex, difficult-to-treat diseases, including IBD and
radiation-induced inflammatory injury.

Complex Signaling Regulates Cell Fate Decisions in IECs
ISCs integrate multiple complex signaling from their microenvironment to drive
cell fate decisions. The highly-ordered nature of IEC turnover within the crypt lends the
system to genetic investigations, as outlined in the previous section of this introduction
[16]. An altered balance in ISC self-renewal and differentiation has an immediate
consequence on crypt-ultrastructure. However, previous investigation has paradoxically
implicated the same cell-intrinisic signaling pathways that promote ISC self-renewal in
driving exit from the stem cell niche under different environmental conditions. Thus, the
dynamic interplay between environmental cues and ISC signaling must also be
considered. Before we begin a thorough investigation into the environmental contexts
that regulate ISC cell fate decisions, we need to establish a clear sense of the basic
signaling pathways inherent to ISCs. To this end, Gehart and Clevers outlined the
essential signaling pathways within ISCs in their recent review [17]. Figure 1.2, from their
review, outlines the basic signaling players identified over the past several decades.
Next, we will examine the current understanding of the contribution of each of these
signaling pathways on ISC self-renewal to contextualize our work in subsequent
chapters.
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Wnt/β-catenin Signaling Primes ISC Self-Renewal
Originally identified in driving Drosophila body-axis polarity and embryonic
development, the Wingless/Int (Wnt) family of genes has now been shown to activate
signaling cascades critical in cell proliferation, carcinogenesis and cell fate decisions in
other organisms, reviewed here: [18]. Not surprisingly, Wnt plays a critical role in the
development and homeostatic activities of the mammalian intestine. Schematic
representation of Wnt signaling can be appreciated in Figure 1.2a in both its Wnt ON
and Wnt OFF conditions. Briefly, to activate the Wnt signaling cascade, a Wnt ligand
engages the Frizzled family of cell-surface receptors. Through ligand engaged-Frizzled
recruitment of its LRP5/6 transmembrane co-receptor, an autophosphorylation event
guides the inactivation of the β-catenin cytosolic destruction complex, consisting of APC,
Axin and GSK3 proteins. [19-21]. Active β-catenin can now translocate to the nucleus to
interact with T-cell factor/Lymphoid enhancing factor (TCF/LEF) transcriptional cofactors
and drive expression of Wnt target genes. In the absence of Wnt ligand, Frizzled (Fzd)
receptors undergo degradation by ZNRF3/RNF43 transmembrane receptors. Within the
cytoplasm, the destruction complex limits cytoplasmic concentrations of the Wnt
transcriptional activator β-catenin through N-terminal phosphorylation and ubiquitindirected degradation via the proteasome, as our lab has shown previously [22].
Within intestinal crypts, the Wnt signaling cascade plays a critical role in intestinal
stem cell homeostasis and crypt ultrastructure through the spatial-restriction of Wnt
responsiveness [23, 24]. At the crypt base, Paneth cells and Foxl1-expressing
mesenchymal cells [25] produce necessary Wnt ligands and metabolic intermediates
essential for the maintenance of ISC stemness. As IECs advance up the crypt-villus
axis, their proximity to Wnt ligands declines—decreasing signal stimulation and
promoting differentiation programs [23, 26]. Therefore, Wnt activation can reliably
identify both pluripotent and multipotent stem cell populations. Our field has established
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that active, high cycling ISCs reside at the base of the crypt are marked by Lgr5-receptor
[2], which binds R-spondin (RSpo) with high affinity to enhance Wnt signal [27].
However, a recent study by Yan and colleagues further clarified Wnt-regulation on ISC
self-renewal [28]. Before their recent work, Wnt and RSpo-dependent effects on ISC fate
decisions were considered to be roughly equivalent in self-renewal promotion. However,
using synthetic Wnt and RSpo ligands, this group neatly demonstrated distinct functional
roles for these ligands. Specifically, overexpressed Wnt ligands alone were insufficient to
promote crypt expansion or ISC self-renewal. Instead, the addition of Wnt ligands
caused a deviation from the default Lgr5+ ISC passive programmed commitment and
created a competent ISC population eager to receive a subsequent activation signal.
Similarly, RSpo stimulation independently could not drive ISC self-renewal due to failure
to unmask their innate receptors and instead served to amplify active Wnt signal. Only
together could Wnt/RSpo co-stimulation drive ISC self-renewal. This cooperative activity
underpins the notion that self-renewal is an active signaling process requiring multiple
cellular inputs. As such, it is likely that similar dedifferentiation programs require active
participation from signaling ligands, including Wnt.
However, Wnt signaling represents only one piece of the puzzle driving
cytodifferentiation of crypt epithelial cells [29]. Crypt ultrastructure similarly relies on the
integration of other key signaling programs, including Notch (Figure 1.2b), Bone
Morphogenic Protein (BMP, Figure 1.2c), and phosphatidyl-inositol-3-kinase (PI3K,
Figure 1.2d) signaling. Notch signaling intersects with active Wnt signaling to drive
secretory fate decisions [30-32], possibly through the dampening of Wnt signal in the
crypt base. However, evidence suggests that Wnt upregulation due to direct Notch
inhibition may actually hinder ISC self-renewal and maintenance programs [33], adding
complexity to the signaling network. Further, secretory metaplasia resulting from direct
Notch inhibition causes drastic deficits in nutrient absorption and bioenergetics of entire
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intestinal crypts—making therapeutic intervention of this pathway less suitable than
other pathways that control IEC metabolism, including PI3K [34]. While BMP signaling
coordinates villus morphogenesis [35], within ISCs PI3K has been shown to mediate the
convergence of BMP and Wnt signaling to promote ISC self-renewal through PTEN [36].
Importantly, a growing body of literature has continually implicated PI3K signaling in
crypt restitution programs, especially in response to inflammation [12]. As such, further
investigation into PI3K-dependent interaction with active Wnt signaling, especially as a
major crossroads for cell fate determination, is warranted.

PI3K-Dependent β-catenin Activation Essential for Self-Renewal
Schematic representation of PI3K signaling can similarly be appreciated in Figure
1.2d. Briefly, PI3Ks are a unique family of lipid kinase signaling, broadly classified into 3
different groups, briefly reviewed here [13]. Class I PI3K system consists of a catalytic
p110 protein that complexes with its p85 regulatory subunit [37]. The p85 subunit
maintains the ability to complex with receptor tyrosine kinases (RTK), and ligand binding
PI3K-associated RTKs kicks off a signaling cascade that ends in the activation of p110
to drive phosphorylation and inactivation of the downstream PTEN regulatory protein
[38]. The major activating protein of the PI3K signaling pathway is Akt, or Protein Kinase
B (PKB). Akt integrates multiple signaling events within the cell and drives diverse
cellular responses based on context, including apoptosis and cell cycle arrest, cell
proliferation and activation and protein synthesis [39]. PI3K was first implicated in ISC
fate decisions after the observation that elevated PI3K can drive ISC self-renewal
paradigms [36]. Further, work by our lab identified a critical interconnection between
PI3K signaling and Wnt signaling, specifically the observation that p-Akt can
phosphorylate β-catenin at its Ser552 residue, driving nuclear localization of β-catenin
[40]. However, the investigations into the specific interactions between PI3K and nuclear
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localization of β-catenin have been unfortunately contradictory [41, 42]. For example,
early findings hinged on the collective observation that p-PTEN-positive cells are
essentially high-cycling ISCs, but further investigation has revealed that p-PTEN positive
cells might also encompass quiescent stem populations and early progenitors residing in
the TA Zone [43]. Adding further complexity to the issue, PI3K-dependent signaling may
alter cellular metabolism and direct exit from the stem compartment [13]. The
observation that “stemness” is not restricted to ISCs [11] begs the question what
pressures drive the reacquisition of ISC signaling paradigms in differentiated cells? The
content of this thesis suggests that PI3K not only plays a critical role in withdrawal of ISC
self-renewal signaling through a shift in cellular metabolism, PI3K also critically factors
into the dedifferentiation and reacquisition of stem characteristics from reserve and
progenitor cell pools.

Metabolism Commits ISCs
The mitochondrion is an essential organelle in cells. In addition to its role in
biosynthetic and metabolic pathways for energy generation the mitochondrion also
participates in cell death decisions via apoptotic programs [44]. Evidence suggests that
decision to pursue self-renewal or differentiation is inherently a metabolic decision, as
primarily glycolytic metabolism characterizes pluripotent stem signatures [45], while a
greater reliance on oxidative phosphorylation (OXPHOS) is a hallmark of differentiated
cell lines [46]. However, whether differentiation is a by-product or consequence of
altered energy requirements remains incompletely understood. Byproducts of
mitochondrial function, including metabolic intermediates and reactive oxygen species
(ROS) generated from electron transport chain (ETC) can act as potent signaling
molecules [47], and therefore could reasonably play a critical role in fate decisions. To
this end, advances in technology to track mitochondrial ROS generation have revealed
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that even modest physiologic changes in ROS can drive cell fate decisions within stem
cell populations, specifically neural stem cells [48]. Recently, Rodriguez-Colman and
colleagues identified mitochondrial-derived ROS as a driving force for ISCs to undergo
differentiation programs through the direct activation of p38-MAPK signaling pathway
[49]. Their work addressed a key gap in the ISC fate decision literature: establishing a
clear link between mitochondrial-derived metabolism and ISC signaling. However,
questions remain. For example, their proposed model requires significant metabolite
contribution from Paneth cells, but Paneth cells are not an essential component of
healthy crypt structures [50]. Do crypts prime differentiation events by promoting
supportive constituents of the stem cell niche? Can redundant metabolic contributors,
possibly through a shift in the intestinal microbiota, replace a depleted Paneth cell
compartment? As such, understanding a cell intrinsic mechanism linking mitochondrial
function with the fluid conversion between ISCs, progenitor cells and differentiated IECs
could shed light on how crypts specifically respond to injury.

Glucocorticoid (GC) Therapy and Suppressing NFκB-mediated Inflammation.
Exogenous glucocorticoid (GC) therapy is a mainstay therapy for inflammatory
diseases. However, in inflammatory conditions of the bowel, complete repression of the
inflammatory response causes an insufficient healing stimulus for injured crypts [51] and
can perpetuate disease. For example, in inflammatory bowel diseases (IBD),
achievement of mucosal restitution at 1-month following treatment initiation is the most
significant prognosticator of disease remission at 1 year [52]. Clinical data in steroidtreated IBD patients show consistent improvement in disease symptoms (decreased
abdominal pain, decreased rectal bleeding, decreased stool frequency) over untreated
controls, while resolution of epithelial ulcers is significantly delayed for unknown reasons
[53]. Mechanistically, GCs have routinely been shown to modulate innate and adaptive
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immune cells, but their effects on IEC signaling remain critically under-characterized
[54]. Within IEC, NFκB drives the survival and restoration of IEC in response to
inflammation [55], and GC-mediated modulation of the NFκB subunit p65 is the major
anti-inflammatory mechanism of GCs [56]. GC hormones enact cellular control by
translocating across the epithelial cell membrane to interact with their cytosolic receptor;
GR. Ligand-engaged GR enters the nucleus to bind glucocorticoid response elements
(GREs) that “transactivate” or “transrepress” glucocorticoid-dependent genes [57, 58].
Interestingly, GR can directly engage in protein-protein interactions with other
transcription factors [6]; and recent evidence has suggested that cell type and disease
state can influence GR ability to recruit unique co-factors [59, 60]. Currently, the impact
of active GR signaling on ISC activation and response to injury is incompletely
understood, but the idea that GR can participate in Wnt directed nuclear cofactors,
including activated β-catenin would help establish a connection between steroid therapy
and decreased mucosal restitution. Thus, understanding the complex signaling
interaction between GR, NF-κB-mediated inflammatory stimulus and Wnt signaling
activation is likely to yield therapeutic benefit in the treatment of IBD, and an additional
goal of the proposed thesis.

Injury to the Intestinal Crypt.
Our lab has extensively studied the role of Wnt signaling in colonic ulcer healing
using mouse models of colitis and human tissue [61, 62]. Activation of ISCs in crypt
structures at mucosal ulcer margins occurs through the Wnt transcriptional co-activator
β-catenin by engaging DNA-bound TCF transcription factors. Specifically, the TNFmediated Akt-phosphorylated form of β-catenin (p-β-cateninSer552) serves as a marker of
activated ISC in colitis [62]. This critical signaling event links PI3K-mediated stimulation
of Wnt signaling to drive ISC activation. Appropriately, we expect that cell-intrinsic or
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exogenous attempts (i.e. through pharmacologic intervention) that result in reduced βcatenin activation have significant effects on ISC-mediated epithelial restitution.
However, despite the significant contributions of PI3K on defining metabolic program
within IECs, the particular intersection of PI3K on Wnt signaling and cell fate decisions
during crypt restitution remains incompletely studied.
Under some injury circumstances, ISC-mediated crypt restitution is compromised
by a significant decline in available stem cells. For example, in response to radiation
injury, the q-ISCs and proliferative progenitor cells must expand to enact crypt restitution
without Lgr5+ ISCs [21, 63-66]. The exact mechanisms these cells employ to convert
back to functional ISCs remains controversial, and as stated previous—remains a critical
focus of the current work. Enhanced PI3K signaling has been linked to radioresistance in
several cancer cell types, including prostate [67] and hepatocellular carcinomas [68],
which made PI3K inhibition an attractive target for treating certain malignancies [69, 70].
Whether PI3K-mediated radioresistance occurs due to tailored cellular metabolism in the
face of scare nutrient availability, or as a direct result of apoptosis inhibition and DNA
damage protection remains hotly debated [71]. In this thesis proposal we ask PI3K
utilizes these same mechanisms to promote a radioresistant pool of cells to respond to
crypt injury.

Introduction Summary and Goals of Dissertation:
The content of this introduction is intended to give you the tools you need to
appreciate the arguments presented in subsequent chapters. As such, a quick summary
of the global points presented in this section should be carried throughout. First, we’ve
attempted to establish that despite high rates of cell turnover along the length of the
crypts, ISC viability and cell fate determinations are perpetually linked with the signals
present in their local microenvironment. This may manifest as a subtle change in cell
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fitness due to sub-optimal contributions from mesenchymal components or a change in
the microbiota present during an inflammatory disease. Or alternatively, the makeup of
the local microenvironment is a direct response to an altered balance in ISC self-renewal
and passive differentiation with genetic alteration. The clinical impact of these shifts is
most appropriately studied in the context of injury. Entrenched within this discussion is
the impact of Wnt signaling as a critical regulator of ISC self-renewal. As referenced,
Yan and colleagues established the non-equivalence of Wnt ligands and the requirement
of cooperative signaling to produce an active self-renewal process. Cooperative
signaling also occurs between Wnt and PI3K, Notch and BMP signaling pathways.
Finally, this introduction asserts that the IEC cell identity is inherently linked to a shift in
energy generation and utilization. Rodriguez-Colman and colleagues establish that
certain pro-OXPHOS metabolic intermediates can override signaling contexts promoting
active self-renewal programs to cause differentiation. All of these pieces of information
help us contextualize the interconnection of ISCs and their microenvironment, and how
perturbation of this symbiosis during injury might be countered by therapeutics to
improve crypt-healing responses.
The goal of this dissertation is to establish the specific contexts that either
enhance or limit ISC response to injury that necessitates activation of a “reserve”
population of cells for crypt restitution. For our purposes, we argue that the cellular
identity of these “reserve” cells is irrelevant to the clinical impact of optimizing treatment
due to the understanding that multiple distinct cell types can all undergo similar
dedifferentiation processes. The implications of this work will jumpstart translational
research for new treatment paradigms in addressing IBD and radiation-induced
enteropathy.
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Chapter 1: Figures
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Figure 1.1: Dynamic Responses of Intestinal Epithelium Under Homeostasis and
After Injury. Copyright © BioMed Central Publishing (van der Heijden et. al., 2019), and
reprinted with permission (attached). (A) Small Intestinal epithelium organizes in cryptvillus structures to perform the dynamic functions of the organ system. ISCs that reside
at the base of the crypt drive constant renewal of the epithelial monolayer, occurring
every 3-5 days. ISCs are supported by their interactions with Paneth cells, mesenchymal
cells and the microbiota. (B) ISCs high-cycling nature causes heightened sensitivity to
cytotoxic injury. As the crypt experiences ISC loss, reserve populations of quiescent
stem cells or multipotent progenitor cells incur dedifferentiation pressure to regenerate
the active ISC pool. Thus, ISCs are an inherently dynamic population of cells that are
generated by asymmetric division under homeostatic conditions, or by dedifferentiation
programs in committed cells under injury conditions.
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Figure 1.2: Signaling Networks in Stem Cells Driving Self-Renewal Capacity.
Copyright © Springer Press (Gehart and Clevers, 2018), reprinted with permission from
SpringerLink (attached). (A) The Wnt signaling cascade in with both presence and
absence of Wnt ligand. WNT OFF: Unengaged RSpo receptors ZNRF3/RNF43 degrade
the natural Wnt ligand Frizzled (Fzd) receptor. Downstream, the cytosolic β-catenin
destruction complex, consisting of Axin, Glycogen Synthase Kinase (GSK) and
Adenomatous polyposis coli (APC) family of proteins, ubiquitinates and causes
proteasomal degradation of β-catenin. WNT ON: Wnt ligand attached causes destruction
complex inactivation—allowing for activated β-catenin to translocate to the nucleus and
bind T-Cell Factor/Lymphoid Enhancer Binding Factor (TCF/LEF) family of transcription
factors. (B) Notch Signaling. Notch Ligands bind to the Notch receptor allowing for γsecretase-dependent release of the Notch Intracellular Domain (NICD) into the
cytoplasm. NICD can subsequently translocates to the nucleus to bind DNA transcription
factors. (C) BMP Signaling. BMP ligands bind BMP Receptors to cause dimerization and
activation of SMAD protein homologues. (D) PI3K and EGF signaling. Binding of growth
factors, including EGF, IGF-1 and HGF, to growth factor receptors leads to receptor
dimerization and phosphorylation of regulator elements (including p85α) restricting the
activation of downstream PI3K affectors, including AKT. AKT intersects with mTOR
signaling and Wnt Signaling through shared regulator GSK3β.
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Chapter 2: Epithelial-specific p85α Ablation Primes Intestinal Crypt Responses to
Radiation Injury Through Enhanced Mitochondrial-Derived ROS Signaling
Introduction
The adult intestine exhibits tremendous flexibility in adapting to cytotoxic insults.
In each intestinal epithelial cell (IEC), diverse yet interconnecting signaling pathways
regulate cellular survival, proliferation, differentiation and response to injury. These
observations underscore the importance of the contexts regulating both homeostatic
conditions and associated injury response. In this regard, we and others have
interrogated the synergistic effects of PI3K and Wnt signaling pathways in ISCs [36, 40].
A central element of the PI3K is the serine/threonine kinase Akt, which interacts with
both pro-growth and anti-apoptotic mechanisms independently to achieve optimal
homeostatic signal transduction within IECs. We posit that discovering cellular contexts
titrating outcomes of Akt activation (pro-growth or anti-apoptosis) to optimize cellular
growth and development signals will lead to a greater understanding of crypt restitution
after injury.
Multiple levels of signal transduction redundancy and cellular control exist
throughout the PI3K pathway. One important regulatory protein is the phosphatase and
tensin homolog (PTEN) protein. PTEN works to directly oppose early stage activation of
the PIP3 messenger lipid [43]. Work from our laboratory established PTEN loss of
function leads to enhanced PI3K/Akt activation, increased β-catenin nuclear localization
leading to excessive ISC activation and crypt formation through fissioning [40]. However,
proteins upstream of this critical junction have garnered significant attention with regard
to PI3K signaling outcomes. Specifically, the p85 regulatory subunits exert the initial
layer of cellular control on PI3K signaling through their interaction with the p110 catalytic
domains. Of note, extensive investigation into the p85α protein shows its critical role in
facilitating lipid phosphatase activity, such that its cellular exclusion negatively impacts
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the regulatory mechanisms limiting PI3K activation. The direct impact of p85α ablation
on PI3K activation and subsequent functional consequences on the intestinal stem cell
niche requires further clarification. To this end, as the tools to study PI3Ks improve, we
only expand our understanding of the diverse outcomes in ISCs.
The dynamic interplay between the supportive constituents of the intestinal crypt,
including Paneth cells, the intestinal microbiome and immune constituents within the
lamina propria, integrate to drive terminal cell fate decisions. Previous investigators have
demonstrated nutrient drives differentiation of ISCs into functional intestinal epithelial
cells (IEC) in a PI3K/Akt/mTORC1 dependent manner using calorie-restriction [43, 72].
Now, work by Rodriguez-Colman [49] and colleagues addressed how the metabolic
profile of the stem cell niche propels cell-cycle progression and stem cell differentiation.
Increased bioenergetic mediators, specifically high levels of lactate from Paneth cells,
directly enhance mitochondrial oxidative phosphorylation in ISCs and lead to increased
crypt differentiation through generation of reactive oxygen species and the triggering of a
p38 MAPK-dependent signaling cascade. The implications of this work are vast: by
altering the metabolomic properties of the intestinal stem cell niche, individual crypts can
increase the number of proliferative progenitor cells (PC)—a population shown to be
increasingly important in the response to crypt injury [73]. PCs of the intestinal crypt are
distinguished from ISCs by the presence of Wingless/Int1 (Wnt) signaling pathway target
gene Axin2 in the absence of known stem cell marker transcript Lgr5—highlighting the
critical interplay of the Wnt signaling pathway and PI3K/Akt/mTOR in cell fate decisions
after injury [36]. However, it remains unclear whether manipulation of these signaling
pathways improves stem cell responsiveness and enhances crypt-healing responses.
Injury mechanisms targeting high-cycling Lgr5+ ISCs [2] established the critical
role of PCs and quiescent ISCs (+4, or q-ISCs) [6] in re-establishing crypt units after
radiation injury [74]. The role of whole body radiation (WBR) in determining critical
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dynamic interchange between ISC and progenitor cell pools has been well-characterized
previously [75, 76]. Interestingly, terminally-differentiated enterocytes can also
dedifferentiate to replenish the ISC pool [11], underscoring the extensive plasticity
demonstrated by cells within the intestinal crypt. The present study utilizes tissuespecific ablation of the p85α regulatory subunit to examine the impact of increased PI3K
signaling on the regenerative paradigm of Lgr5+ ISCs, q-ISCs and Axin2+ progenitor cells
after radiation injury. Based on previous research studies, this specific injury mechanism
targets high-cycling Lgr5+ ISCs [2]. Therefore, the work contained within this manuscript
elaborates on activated PI3K signaling as a driving force for priming crypt IEC ISC/PC
populations to improve their responses to injury. Our findings suggest that enhanced
epithelial PI3K signaling optimizes mitochondrial respiration, which potentiates ISC/PC
participation in IEC recovery from radiation injury.
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Methods
Animals. All studies were performed according Northwestern University and University of
Kentucky Institutional Animal Care and Use Committee protocols. C57Bl/6 Villin-Cre
mice were bred with p85fl/fl mice (a generous gift of Cantlay Lab [77]) to create progeny
carrying a constitutive knockout of p85 (p85ΔIEC mice), the class IA regulatory subunit of
PI3K, in mouse IECs. This model has been validated to specifically investigate β-catenin
signaling in the maintenance of intestinal cells, and has been published by our lab
previously [62]. 8-12 week old mice were used for study. Age-matched, p85+/+ C57Bl/6
littermates were used as wild-type (WT) controls. Animals were kept under specific
pathogen free (SPF) conditions and allowed access to chow and water ad libitum. To
induce radiation damage, the mice were exposed to 12Gy of whole body radiation
(WBR) and examined 24 hours or 3.5 days following insult. For cell proliferation studies,
mice were given a single intraperitoneal injection of 1 mg of BrdU 2 hours prior to
euthanasia. All mice were euthanized by CO2 asphyxiation and cervical dislocation.

Murine Intestinal epithelial cell purification. Intestinal epithelial cells were purified using
whole crypts in as previously described by this lab [62, 78] and adapted based on recent
work [79]. Briefly, lengthwise sections of intestine were washed in 4°C Ca2+- and Mg+free HBSS (CMF-HBSS). The tissue was transferred to CMF-HBSS containing 10 mM
dithiothreitol and 50 nM calyculin A and 250 µM EDTA (Calbiochem) for 15-30 minutes,
4°C. Tubes were shaken and then tissue was transferred to fresh tubes containing CMFHBSS with 1 mM EDTA, 4°C for 1 hour. Epithelial cells were then dislodged by vigorous
shaking. Large pieces of tissue were discarded. Resultant epithelial cells were harvested
by centrifugation at 500xg for 10 minutes. IECs were snap-frozen in liquid nitrogen and
stored at –80°C until use. From this point, purified IECs were utilized for nucleic acid or
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protein analysis, or further fractionated to isolate whole mitochondria for bioenergetics
measurements.

Isolation of mitochondria from intestinal epithelial cells. The mitochondrial isolation
technique was adapted from [80, 81] and carried out on ice or at 4°C. First, IECs were
isolated as above. Then, resultant cell pellets were washed with 2ml ice-cold
mitochondrial isolation buffer (MIB, 215 mM mannitol, 75 mM sucrose, 0.1 % BSA, 1 mM
EGTA, 20 mM HEPES, pH 7.2) and the pellets were respuspended immediately in 0.5
ml MIB. The cells were lysed by subjecting them to 1300–1400 psi pressure in a N2
chamber for 10 min at 4 °C following by passing them two times through 25-gauge
syringe. The resultant suspensions were topped with MIB to 2ml and were centrifuged at
1,300 g for 3 minutes. The supernatent was carefully transferred into 2-ml tubes. The
tubes were centrifuged at 13,000 g for 10 minutes. The pellet was resuspended into
1.5ml tubes and were transferred to 1.5ml tubes and centrifuged at 13,000 g for 10
minutes, and the supernatant was discarded. The mitochondrial pellets were suspended
in MIB without EGTA to achieve an approximate concentration greater than 10 mg/ml,
and the protein content was measured using a BCA kit (Thermo Fischer Scientific,
catalog 23227) according to the manufacturer’s instructions.

Mitochondrial bioenergetics. Using isolated mitochondria from IECs, we assessed
mitochondrial bioenergetics using XFe24 Seahorse (Agilent technologies) as previously
described [80, 82]. Briefly, Mitochondrial OCR were measured at 37°C in the presence
of respiration buffer (125 mM KCl, 2 mM MgCl2, 2.5 mM KH2PO4, 20 mM HEPES, pH
adjusted to 7.2) with stepwise injections of (Pyruvate + Malate + Adenosine diphosphate
(ADP)) through port A to induce State III (maximal, coupled ATP production); Oligomycin
through port B to induce State IV (proton leak across inner mitochondrial membrane);
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FCCP through port C to induce State VCI (complex I driven uncoupled respiration) and
(Rotenone + Succinate) through port D to induce State VCII (complex II driven uncoupled
respiration).

Mitochondrial ROS and membrane potential. The mitochondrial ROS production and the
inner membrane potential were determined fluorimetrically using a fluorescent plate
reader (Synergy HT, Biotek). For both the assays the isolated mitochondria (10ug) were
plated in 100ul respiration buffer and were energized with pyruvate and malate. The
mitochondrial membrane potential was determined using 2.5 uM tetramethylrhodamine
ethyl ester (TMRE) and measuring the fluorescence at λex 530nm and λem 590 where as
ROS production was determined by addition of Amplex red followed by measuring the
fluorescence at λex 485nm and λem 528nm. Both the assays were carried out in the
presence of Oligomycin or FCCP in order to determine the ROS production and
membrane potential in the maximal energized or de-energized states of the
mitochondrial membrane. The results are represented as the difference between the two
states.

Western Blotting. IEC were extracted as described above. All buffers contained Protease
ArrestTM (G-Biosciences, St. Louis, MO) protease inhibitor mixture and phosphatase
inhibitors I and II (Sigma) at a concentration of 1:100. 30 ug protein was suspended in
LDS NuPage buffer (Invitrogen) with 10% 2-mercaptoethanol. Samples were boiled at
95° and resolved using SDS-PAGE. Proteins were transferred on Immobilon FL
(Millipore) by semi-dry transfer methods (Bio-Rad) and washed with 1x TBS solution with
0.05% Tween-20 and blocked for 1 hour at RT with Pierce Protein-Free T20 Buffer.
Antibodies used for WB analysis are listed in Supplementary Table 1 at the end of this
paper. Primary antibodies diluted 1:1000 in Buffer were incubated on membranes at 4°
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overnight, washed with TBS x 4 times for 10 minutes each, before a 1 hour incubation
with 0.02 ug/mL secondary antibody. After TBS washing, membranes were developed
using West Dura solution (Thermo Scientific) and imaged.

Immunohistochemistry. Tissues were fixed in 4% neutral buffered formalin overnight,
processed through paraffin and sectioned at 7 µm before analysis. Antigen retrieval of
formalin-fixed paraffin sections used Target retrieval solution (Dako, Carpinteria, CA)
and a decloaking chamber (Biocare medical, Concord CA). Sections were incubated
overnight with anti-BrdU (1:250, Accurate Chemical, Westbury, NY) or anti-survivin
(1:250, Novus Biologicals, Centennial CO). Sections will be incubated with anti-rabbit
HRP labeled polymer (BrdU) or anti-rat streptavidin (survivin) (Dako). Stained slides
were developed using 3,3’-diaminobenzidine tetrahydrochloride (Dako) and then
counterstained with hematoxylin. For counting cells at specific crypt positions at least
100 well-oriented crypts from 4-5 mice per group were captured using at 40x
magnification using an Olympus upright microscope and analyzed using ImageJ
software (U. S. National Institutes of Health, Bethesda, Maryland, USA), as described
previously [78]. Crypts with greater than 5 BrdU positive cells per crypt were assessed to
be viable, as previously described [78].

Paneth Cell Counts and Area Measurement. Histological samples from 8-12 week old
mice prepared as above, and subjected to hematoxylin staining with eosin Y
counterstain using established protocol [62]. Samples were analyzed grossly at low
magnification before high-magnification images were taken using an Olympus upright
microscope and uploaded to imageJ software, where Paneth cells were counted
individually and areas were outlined and aggregated. 10 high-powered fields of view
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were utilized from each slide, and at least 10 slides were utilized per animal (n=5 for
both WT, p85ΔIEC mice).

In Situ Hybridization. Tissues were fixed in 4% neutral buffered formalin overnight,
processed through paraffin, sectioned at 5 µm before analysis. Formalin-fixed paraffin
embedded sections were analyzed using the RNAScope 2.0 2 Plex Chromogenic
Detection Kit (ACDBio, Newark, CA) described previously [83]. After pretreatment, slides
were subjected to RNAScope probes designed to hybridize against mRNA for mouse
Axin2 and Lgr5. Targeted RNA was amplified using provided amplification reagents and
slides, incubated in the RNAScope hybridization oven and counterstained with
hematoxylin before microscopic analysis.

Real-Time PCR. Total RNA was isolated from intestinal epithelial cells using the RNeasy
Mini Kit (Qiagen, Valencia, CA) and reverse transcribed using High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Real time PCR used
the ABI Step OnePlus real-time PCR system and Power SYBR green PCR master mix
(Applied Biosystems). Primers were designed by Primer Express software 3.0 (Applied
Biosystems) based on nucleotide sequences from the National Center for Biotechnology
Information data bank. For each sample, beta-actin and 18S were used as a pooled
internal reference. All assays were performed in triplicate and fold changes were
calculated using the ΔΔCT method.

Deep Sequencing of Mouse Fecal Pellets for Microbiome Analysis. Fecal pellets of 8-12
week old mice were directly excised from the ileum and flash frozen in LN2. Samples
were shipped on dry ice to University of Florida (Gainesville, FL) for analysis by the
Mohamadzedah lab as previously described [84]. Briefly, DNA from fecal samples was
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isolated using a ZymoBIOMICS DNA MiniPrep kit (Zymo Research, USA). The V4-V5
region of 16S ribosomal DNA was PCR amplified using primers as described previously
[85]. The libraries were quantified by a KAPA Library Quantification kit (Kapa
Biosystems, USA) and sequenced on an Illumina MiSeq using a MiSeq Reagent Kit V2
(Illumina, USA). Sequence analyses were performed using QIIME v.1.9.0. An open
reference operational taxonomic unit (OTU) picking strategy was used, and taxonomy
was assigned based on the Greengenes reference database. Subsequently, a
taxonomic table for each taxonomic level was generated, and significantly differential
features at each level were identified using linear discriminant analysis (LDA) along with
effect size measurements (LEfSe)25. The taxons were filtered by LDA Effect Size
(LEfSe) analyses with default criteria (P < 0.05 by Kruskal-Wallis test; LDA score > 2).

Statistical Analysis. Statistics were performed using GraphPad Prism 8.0 Software. All
pairwise comparisons were made using a Student’s t-test with post-hoc Holm-Sidak
correction. p < 0.05 was considered statistically significant. Comparisons among multiple
groups were made using a one-way ANOVA with post-hoc Tukey’s test. Values
represent means ± standard error of mean unless otherwise specified.
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Results
Ablation of p85α IEC Alters Stem and Progenitor Cell Signaling within the Intestinal
Crypt.
To examine the impact of IEC-specific pik3r1 (p85α) deletion on IEC PI3K
signaling, WT and p85ΔIEC IEC protein lysates were examined. Western blot analysis
indicated that pik3r1 deletion (Class IA PI3K) led to decreased p85α protein levels in
p85ΔIEC mice (Figure 2.1A). To investigate the role of p85α affects homeostatic PI3K
signaling, we examined inactive regulatory proteins (p-PTEN), and activated
downstream signaling constituents (Figure 2.1B). Wnt targets GSK3β and Survivin were
assessed to appreciate dual activation of Wnt signaling after p85α ablation [86]. Results
show that p85a deficiency enhanced p-PTEN/PTEN ratios (2.5-fold) and increased
levels of activated p-Akt and p-GSK-3β by >6-fold. Not surprisingly, p-β-catenin552 and
Survivin protein levels increased greater than 2-fold in p85ΔIEC mice consistent with
increases Wnt signaling.
Given that protein analyses show that IEC p85α loss inherently increases both
PI3K and Wnt signaling, we assessed IEC transcriptional responses by measuring
mRNA for Wnt target and ISC-related genes. Data in Figure 2.1C show that IEC from
p85ΔIEC mice expressed significantly increased levels of Wnt target genes, Axin2, c-myc,
and Cyclin-D1 compared to WT counterparts. Further, traditionally quiescent or latent
stem cell pool markers, (including HopX and Bmi1) were elevated, while levels of Lgr5,
indicative of active high-cycling ISCs, were significantly depressed (>25% reduction,
p<0.05) in p85ΔIEC mice compared to WT mice. Depressed Lgr5 and elevated Axin2 RNA
transcription prompted further investigation of PI3K signaling on ISC and progenitor cell
pools. Using proprietary ISH probes from RNAScope Technologies [83], we visualized
the increase in total Axin2 (red) transcripts along the full length of the crypt in p85ΔIEC
mice coincident with depression of Lgr5 (blue) transcripts at the base of the crypts
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(Figure 2.1D) demonstrating an increase in the progenitor cell pool at the expense of
active-cycling ISCs.

Altered Stem and Progenitor Cell Pools Results from a Shift in Zones of Proliferation.
To examine the impact of enhanced PI3K signaling on proliferative cells of the
intestinal crypt, IEC proliferation was assessed by BrdU incorporation in vivo. Findings in
Figure 2.2 show peak levels of IEC proliferation within the transit-amplifying zone (TA
zone) between positions 8 and 10. Analyses of BrdU staining in p85ΔIEC mice reveal
enhanced PI3K signaling shifts IEC proliferation to areas lower in intestinal crypts (Fig.
2.2C). Specifically, IEC at positions 2 and 4 increased BrdU incorporation by 13% and
20% respectively in p85ΔIEC mice. In general, these data argue that enhanced PI3K
signaling promotes IEC proliferation in the more pluripotent, lower crypt ISC/PC
populations that express the Wnt target, Axin2.

Enhanced PI3K Signaling Stimulates Secretory Lineage Differentiation and Drives
Mitochondrial Respiration within the Crypt.
Given changes in ISC/PC populations observed in p85ΔIEC mice, we next
examined whether altered PI3K signaling impacted lineage commitment within the crypt.
Data in Figure 2.3A showed IECs harbor increased Paneth cell markers EphB3 (5-fold
change) and MMP7 (2-fold change), as other secretory lineage determinants, including a
Math1 (1.3-fold change), SPDEF (2-fold), and Gfi1 (4.5-fold, major Goblet cell transcript)
with a subsequent decrease in Notch-target gene Hes1 by 60% (p<0.05) (Figure 2.3A).
Overall, the results suggest that enhanced PI3K signaling in ISC/PC compartment led to
reduced Notch and subsequently enhanced Math1/Atoh1 signaling. To evaluate the
signaling impact on IEC phenotype, image analysis on histological samples was
performed. Data in Figure 2.3B-C revealed an increase in the total number of Paneth
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cells (8.58 vs. 6.12 cells per crypt) and a 23% increase in total surface area of each
Paneth cell (126.35 µm2 vs. 97.84 µm2). Analysis of goblet cell staining failed to detect
significant changes (data not shown). Thus, enhanced PI3K signaling resulted in
enhanced lineage commitment of IEC to the Paneth cell phenotype.
We next asked if the selective differentiation pressure toward a secretory
phenotype directly impacted mitochondrial respiration. RNA isolated from IECs showed
1.5 to 4-fold increase nuclear-encoded protein transcripts involved in oxidative
phosphorylation (OXPHOS), including ATP8 and ND1 with 4 to 5-fold decreases in
transcripts encoding enzymes involved in glycolysis, including the GLUT1 transporter
and HK2 (Figure 2.3D). To assess mitochondrial function, we analyzed bioenergetics
profiles using Seahorse. We tested mitochondria isolated directly from IECs. Compared
to WT, p85ΔIEC mice demonstrated enhanced ADP-dependent ATP production (State III)
(Figure 2.3E), which caused a trended increase in respiratory control ratio (State III/State
IV) (Figure 2.3F). While maximum electron transport driven by Complex I (NADH
dehydrogenase) and Complex II (Succinate dehydrogenase) both showed a trend
toward increases in p85ΔIEC mice, these differences were not statistically significant.
Overall, analyses of IEC mitochondria were consistent with the notion that enhanced IEC
PI3K signaling led to increased maximal capacity for mitochondrial respiration.
Interestingly, enhanced PI3K signaling also resulted in a significant change in the
characteristics of each SI microbiome (Supplemental Figure 2.1). After isolating fecal
pellets by direct excision from the distal ileum, 16S ribosomal DNA was purified for
microbiome analysis. Figure 2.S1A demonstrates the linear discriminant analysis (LDA)
along with effect size measurements (LEfSE Plot) showing p85ΔIEC mice preferentially
select for a microbiome rich in Lactobacillus spp. and Neisseriacaea spp. WT littermates,
in contrast, favor more Bacteroidetes spp. Figure 2.S1B demonstrates that enhanced
PI3K signaling decreases microbial diversity, as both Shannon and Simpson indices of
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biodiversity decreased in p85ΔIEC mice compared to WT controls. Further, microbial
richness was affected, as p85-ablation decreased overall taxonomic units, or OTUs,
within the distal ileum. In line with this data, the Chao1 coefficient of microbial richness
also appropriately decreased. The resultant Cladogram is demonstrated in Figure
2.S1C. Taken together, these data indicate that epithelial cell signaling is sufficient to
shift the composition of the microbiome despite similar activity level and energy
consumption.
Reactive oxygen species (ROS) can be a byproduct of enhanced respiration. In
the right context within the intestinal crypt, ROS acts as a potent signaling molecule [47].
Using dichlorofluorscin diacetate (DCFDA) as a marker of ROS in isolated mitochondria,
we demonstrate that enhanced PI3K signaling appreciably increased mitochondrialderived ROS generation in the transition from State III to State IV respiration (Figure
2.4A). Using uncoupling proteins or by lowering the mitochondrial membrane potential,
the mitochondria can limit the steady production of ROS [47]. However, p85ΔIEC mice
display an enhanced absolute difference membrane potential than WT counterparts in
the membrane energized (Oligomycin) and de-energized (FCCP) states, suggesting
greater ROS production and release (Figure 2.4B). The result of this ROS generation
causes an appreciable activation in p38-MAPK, as levels of phosphorylated-p38 protein
compared to total p38 protein are elevated more than 4-times in p85ΔIEC mice compared
to WT mice (Figure 2.4C).

Enhanced PI3K Primes the Epithelial Compartment to Respond to Radiation Injury
To investigate changes in the ISC and progenitor cell dynamics after direct ISC
injury in our novel animal model, we utilized the whole-body irradiation (WBR). After
subjecting the animals to 12 Gy WBR, we examined the effect of radiation injury on
epithelial cell proliferation at 24-hrs and 84-hrs after insult (Figure 2.5A-C). Analysis of
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BrdU incorporation suggests that radiation injury shifts the zone of proliferation from the
TA Zone to the stem cell compartment (position 0-4) of the hemicrypt in WT mice (Figure
2.5D), where the greatest extent of radiation damage has taken place. In contrast,
primed p85ΔIEC mice have already begun to increase proliferation in the TA Zone, where
the progenitor cells reside. The dichotomous zones of proliferation have a meaningful
impact on total crypt survival at the 84-hour time point (72% crypt survival in WT vs. 85%
crypt survival in p85ΔIEC) (Figure 2.5E). This change in surviving crypt units had a
consequential change in whole organism survival after lethal irradiation, as ΔIEC mice
subjected to 12 Gy whole body radiation lived approximately 2 days longer than WT
counterparts (Figure 2.5F).
To examine dynamic changes in stem and progenitor cell gene expression during
the healing paradigm, qPCR was performed on IECs from WT and p85ΔIEC mice at 0, 24
and 84 hours post radiation injury. In the post-injury period, p85ΔIEC mice are able to
more swiftly replenish their stem and progenitor cell pools, despite starting with fewer
Lgr5+ cells at baseline (Figure 2.6A). Similarly, 24hr and 84hr after radiation damage,
IECs from p85ΔIEC mice significantly enhance expression of Wnt-target genes Axin2 and
Survivin as compared to WT counterparts (Figure 2.6B-C). Close examination of 84
hours after radiation injury with ISH showed both better crypt orientation compared to
WT counterparts, and enhanced Lgr5 transcript localization in the base of the crypts
(Figure 2.6D). IHC with Survivin antibody in WT vs. p85ΔIEC mice 84 hours post injury
shows meaningful increases in Survivin protein levels that track the entire length of the
crypt in p85ΔIEC mice (Figure 2.6E).
Using human colon tissue, we analyzed Survivin localization in the healing
intestine after radiation injury. Using histological samples from 5 radiation proctitis
patients collected from the University of Kentucky’s Biospecimens Core (UL1TR001998)
and comparing to age-matched control colonic tissues, we performed IHC for human
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Survivin. In resting colonic tissue, Survivin expression localizes to the bottom one-third
of the crypt (Figure 2.7A). Following multiple cycles of radiation, intestinal epithelial cells,
and mesenchymal constituents of the lamina propria appropriately upregulate Survivin
protein levels (Figure 2.7B), indicating this protein expression is predictably conserved in
the post-radiation injury process.
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Figure 2.1: p85α ablation in intestinal epithelial cells enhances PI3K, Wnt signaling
pathways, leading to shift in active ISCs, progenitor cells. (A) Western blot analysis
of crypts isolates from 8-12 week old wild-type (WT) and p85ΔIEC mice (ΔIEC). (B)
Densitometric analysis comparing band density of ΔIEC to WT protein lysates. (C) RTPCR analysis of Wnt target (Axin2, c-Myc and CyclinD1) and intestinal stem cell (ISC)
gene signatures (Lgr5, Sox9, Ascl2, HopX, mTert, Bmi1 and Lrig1) from mucosa of WT
and p85ΔIEC mice. Actin used as reference gene *p<0.05 unpaired t-test with Holm-Sidak
correction. n=3-5 mice per group. (D) In Situ Hybridization demonstrating the shift in
high-cycling active stem cells (Lgr5, Blue) from proliferative progenitor zones (Axin2,
Red).
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Figure 2.2: p85α ablation Leads to Altered Zones of Proliferation in Intestinal
Crypts. (A) 2-hours before sacrifice, mice were injected with 1 mg/mL BrdU
intraperitoneal, had their distal ileum isolated, IHC performed and counterstained with
hematoxylin. (B) Position of BrdU+ cells within each hemicrypt was determined using
high power magnification and computer processing. (C) Proportion of cells at each
position that were BrdU+ presented over the total number of cells counted at that
position. Blue: Stem cell zone. Red: Differentiated zone. *p<0.05 Multiple t-tests
performed at each position analyzing the mean differences between groups ± SE.
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Figure 2.3: Elevated PI3K signaling Stimulates Paneth Cell Lineage, Mitochondrial
Respiration in Stem Cell Niche. (A) RT-PCR analysis was performed on mucosal
isolates for detection of Paneth cell-related transcripts MMP7, EphB3, Lyz1, Lyz2,
Reg3g, Ang4 and DefA. (B) Average area (um2) and number of Paneth cells counted per
crypt in WT and p85ΔIEC mice, n=3-5 mice per group. (C) Hematoxylin and Eosin staining
of small intestine from 8-12 week old mice at baseline highlight expansion of Paneth
cells at the base of the crypt. Scale = 100um (D) RT-PCR analysis for differences in
mitochondrial complex transcripts and transporters and enzymes involved in glycolysis.
(E) Mitochondrial bioenergetics measured from isolated mitochondria, highlighting
differences in State III, State IV and State V (Complex I) and (Complex II). (F) RCR
calculated as State III respiration over State IV. * p<0.05 unpaired t-test. mean ± SEM.
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Figure 2.4: Increased Mitochondrial Respiration Drives Mitochondrial ROS
Production to Activate p38 MAPK. (A) DCFDA measurements on isolated
mitochondria from crypt epithelial cells from WT and p85ΔIEC mice. (B) State difference in
observed ROS generation with addition of Oligomycin and FCCP compounds. (C) WB
analysis of IECs for p-p38 MAPK activation, and associated densitometry using total pp38 signal over total p38 protein levels. * p<0.05, **p<0.01 values represent mean ±
SEM.
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Figure 2.5: p85ΔIEC Mice Have Improved Survival Phenotype After Lethal Radiation
Dosage Through Early Crypt Restitution. Proportion of cells at each cell position (See
Figure 2B) that were BrdU+ presented over the total number of cells counted at that
position at Baseline (A), 24 hr after 12 Gy Whole-Body Irradiation (B) and 84 hr after 12
Gy Whole-Body Irradiation (C). Blue: Stem cell zone. Red: Differentiated zone.
(D) Representative BrdU images for counts in A-C. (E) Percentage of surviving crypts
(as defined as >5 BrdU+ cells per crypt [78]) at baseline, 24 hr after 12 Gy Radiation and
84 hr after 12 Gy radiation. (F) Organism survival as measured in days after lethal
radiation dose. n = 6 for WT and p85ΔIEC mice. *p<0.05 values represent mean ± SEM
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Figure 2.6: p85ΔIEC Mice Re-establish Critical Stem and Progenitor Cell Pools More
Rapidly than WT Counterparts Following Radiation Injury. Relative rate change of
expression levels of (A) Lgr5 and (B) Axin2 transcripts after radiation injury. Values
charted over 0, 24 and 84 hours post-injury stimulus. (C) Representative ISH images of
Lgr5 and Axin2 84 hours after radiation injury, with magnification highlighting crypt
orientation and transcript resolution.
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Figure 2.7: Increased Survivin Protein Essential to IEC Radiation Responsiveness,
and is Conserved in Humans. (A) Relative rate change of expression for Survivin
transcript after radiation injury. Values charted over 0, 24 and 84 hours post-injury
stimulus. (B) Survivin protein levels by IHC in WT and p85ΔIEC 84 hours after radiation
injury. (C) Survivin staining in normal human crypts, and post-radiation injury.
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Supplemental Figure 1: Enhanced PI3K alters the composition of the SI
Microbiome. Stool isolated from from distal ileum of WT and p85ΔIEC mice was flash
frozen for microbiome analysis by 16S ribosomal DNA sequencing. (A) LEfSe plot
demonstrating enhanced PI3K signaling (p85ΔIEC, green) preferentially increases
Lactobacillus spp. and Neissriacaea spp., whereas Bacteriodetes spp. distinguish
control microbiota (WT littermates, red). (B) Alpha diversity measures were estimated
based on the observed taxonomic units (OTUs). Microbial Richness measured using
Chao 1 criteria. The Shannon Index accounted microbial evenness (measured by
Simpson’s Index), which demonstrated a decrease in richness and diversity of the
microbiome in p85ΔIEC –mice. (C) Cladogram illustrating the relationship between the
species defining each phenotype.
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Table 1: Antibodies for WB and IHC
Antibody
Actin
p85α
p-PTENSer380
PTEN
p-AktSer473
Akt
p-GSK3βSer9
p-β-catSer552
Survivin
p38 MAPK
p-p38T180/Y182 MAPK

Company/Catalog #
Cell Signaling/4968
Millipore/06-195
Cell Signaling/9551
Cell Signaling/9559
Cell Signaling/4058
Cell Signaling/9272
Cell Signaling/9336
Gift from Linheng Li, Stowers
Novus/NB-500-201
Cell Signaling/9212
Cell Signaling/9211
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Focused Discussion
Data from the current studies present novel signaling context to the step-wise
restitution of intestinal crypts following radiation injury. At baseline, constitutive PI3K
activation enhances progenitor cell pools (Fig 2.1D, 2.2A-C) and promotes transition
from ISCs to secretory cells (Fig 2.3A-C), despite increased Wnt signaling (Fig 2.1A).
This differentiation pressure seems to result from a metabolic shift within the crypt—as
mitochondrial bioenergetics revealed elevated OXPHOS and increased mitochondrialdervied ROS (Fig 2.3E, 2.4A-B). Elevation in ROS coordinates through p38-MAPK
signaling to drive differentiation(Fig 2.4C), in agreement with work done by previous
investigators [49]. The removal of the ISCs from the crypt base promotes “reserve” (qISCs, proliferative progenitors) cell activation to replenish depleted stores, and the
alteration in cellular composition of individual crypts decreases the richness and diversity
of the intestinal microbiome (Supplemental Fig 2.1A-C). In total, this phenotypic change
(depletion of the ISC pool in favor of more committed progenitors) prepares the
organism to weather an injury stimulus targeting high-cycle stem cells. Despite initially
supporting crypts with fewer ISCs per crypt (Fig 2.1D), p85ΔIEC crypts more readily
repopulate radiation-damaged crypts with functional ISCs (Fig 2.6C), suggesting
plasticity in converting reserve stem/progenitor cell compartment back to high-cycling
stems. Finally and importantly, the human data (Fig 2.7) from this study provide
preliminary evidence that the same pathways governing crypt restitution in our novel
mouse model are conserved, indicating a possible clinical correlate to the data provided.
Using a Villin-Cre constitutive promoter was a critical component of the present
studies. Whereas SI IEC from p85ΔIEC mice showed elevated PI3K signaling and
subsequently increased Akt-phosphorylated β-catenin, previous work by our group using
T-cell specific injury stimulus in pik3r1-deficient mice demonstrated attenuated Akt
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activation compared to WT littermates [78]. There are two important differences in these
models. First, Lee et al. utilized an Ah-Cre system—an inducible, dose-dependent
ablation responsive to intraperitoneal injection of β-naphthoflavone [87]. And second,
their studies utilized a T-cell dependent mechanism to trigger pathologic Akt activation
above baseline. Our current experiments show Villin-Cre driven p85α ablation is a cellintrinsic genetic disruption leading to increased baseline Akt activation. The integrity of
the AhCre system for epithelial specific recombination within the GI tract is considered
high—occurring 24 hours after injection and lasting up to 6 months after injection [78].
However, these mice do not cover all intestinal epithelial cells of the crypt, namely
Paneth cells [88]—which previous investigators have established as critical mediator of
nutrient responsiveness in the stem cell niche [49]. Further, work by Bohin and
colleagues demonstrated that confounding effects that occur with inducible VillinCreERT2 system. These investigators observed impaired capability of radiation-treated
mice to form organoids in vitro and delayed crypt restitution in vivo compared to ISCspecific genetic promoters [89]. As such, our Villin-Cre model [90] allows for high vertical
(within all cells of the crypt equally) and horizontal (along all sections of the small
intestine) fidelity of gene manipulation with minimal drawbacks for our specific injury
mechanism. Using this approach, we identified novel alterations in Paneth cell activity
and changes in characteristics of the intestinal microbiome—both seemingly leading to a
change in IEC mitochondrial activity. Further studies are needed to mechanistically link
mesenchymal cells and microbiota driving mitochondrial activation at the substrate level
in IECs, but in total, our data suggest constitutively enhanced PI3K signaling shifts stem
and progenitor pools before the injury stimulus, which makes priming the intestinal crypt
critical for the optimal response to radiation damage.
Supporting cells of the stem cell niche can similarly integrate cues from their
surrounding microenvironment to drive fate decisions. Previous investigators have

49

reported Akt-mediated elevation in Wnt signaling simultaneously altering stem
cell/progenitor cell self-renewal programs and secretory cell maturation [31], suggesting
each cell type interprets the same stimulus differently. Our study reveals that enhanced
PI3K signaling increases the size and number of Paneth cells and alters the crypt
metabolic activity—in line with previous work in Drosophila [91] and caloric-restriced
mice [72]. These data further align with the long held belief that as the number of Lgr5+
cells within the crypt decreases (as seen in the current study), Paneth cell surface area
proportionally increases [92].
Interestingly, our data are the first to implicate enhancing PI3K in the epithelial
compartment promotes changes in the microbiota. Our data demonstrates an increase in
Lactobacillus spp (Supplemental Fig 2.1). These data are unexpected, but most likely
indicate that differentiation pressure may be a direct result of nutrient availability within
the niche, in agreement with others [49, 72]. For example, Lee and colleagues
demonstrated that oral refeeding of lactate-producing bacteria strains, including
Lactobacillus spp., was sufficient to induce epithelial cell differentiation in Lgr5+ cells
[93]. These investigators determined this interaction was dependent on Paneth cellspecific Gpr81-lactate intermingling, linking changes in Paneth cell composition,
metabolism and the microbiota. Lactobacillus spp. have traditionally played a critical role
in radiation responsiveness, as enteral administration of these bacteria act in a dosedependent manner to protect animals from severe gut injury caused by chemotherapy or
radiation [94, 95]. With this in mind, our data further suggest that epithelial cells naturally
shape the crypt niche-intestinal microbe interactions through increased PI3K signaling.
Whether this is a cell-intrinsic property of p85-deficient crypts or a consequence of
altered signaling requires further investigation. Further, the contribution of microbial
metabolite—namely distinguishing between microbial-derived lactate and Paneth cell
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lactate—may provide insight to the direct mechanisms driving metabolic activity and
differentiation pressure.
In the past decade, investigators have started to appreciate the metabolic impact
on ISC self-renewal paradigms. ISCs receive critical signaling intermediates, including
Wnt ligands and carbon chains for cellular respiration, from Paneth cells and
mesenchymal support cells [96]. However, the role of ROS as a toxic by-product of
metabolic programs, rather than a key signaling intermediate, continues to dominate the
basic science and clinical literature [97, 98]. Data in the current studies support ROS
signaling events coordinate the delicate balance between stem cell quiescence,
activation and eventual differentiation. Specifically, cells isolated from p85α-deficient
crypts generate more ROS through enhanced State-III activity of mitochondria (Figure
2.3E, 2.4A-B). Our results corroborate previous evidence implicating State-III-generated
ROS driving differentiation potential in other tissues [99]. These investigators found that
the ROS-mediated transition from undifferentiated mesenchymal stem cells to
adipocytes was sensitive to antioxidants against Complex III. Our Complex III-derived
ROS correlates with elevated activation of p38-MAPK (Fig 2.4C), which has previously
been linked to differentiation protocols within the stem cell niche [49]. Appropriately, the
p38-MAPK activation seen in our current studies may suggest a direct mitochondriadependent signaling mechanism for ROS driving intestinal stem cell proliferation, and
exit from the stem cell compartment as seen by our ISH experiments (Fig 2.1C).
Additionally, previous work by Kabiri and colleagues demonstrated the role MAPK
suppression plays on maintaining the intestinal stem cell pool [100].
Research in adult colonic epithelial cells reveals a strong intersection between
ROS, the PI3K/Akt/mTOR, Wnt/β-catenin and Notch pathways in cell fate decisions
[101] through the NADPH-oxidase 1 (NOX1) protein. However, NOX1 expression within
small intestinal tissues yields conflicting results—ranging from completely absent [102]
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to the primary sensor of microbial and epithelial-derived ROS [103]. Further investigation
to ROS sensing mechanisms, including Nox1, within the epithelial compartment could
yield an important mechanistic link between ROS signaling and differentiation. Especially
considering the known alterations in the intestinal microbiome and decreased sensitivity
to radiation injury. Taken together, our data demonstrate mitochondrial respiration and
ROS generation prime epithelial cells against radiation damage, suggesting further
investigation into noninvasive strategies toward enhancing OXPHOS in epithelial cells
might yield therapeutic benefit in radiation-induced intestinal injury.
Our investigation in radiation-induced colitis revealed that Akt-mediated
increased Wnt signaling is a hallmark of radiation responsiveness of IECs, however the
implications of this signaling change remain unclear. Although WT mice and normal
colonic tissue responded to radiation injury with increased Survivin protein levels,
enhancing PI3K in IECs dramatically increased the Survivin protein response to radiation
injury above controls, suggesting that PI3K might play a critical role in radioprotection of
IECs. While PI3K-dependent Wnt signaling (Fig 2.6-2.7) has been shown to promote
radioprotection in other models of radiation injury [104], previous investigators have
implicated the critical role of YES-associated protein (YAP) in regeneration of Lgr5+
ISCs after radiation injury [105]. Specifically, these authors demonstrated that YAP
coordinates ISC reprogramming by initially inhibiting Wnt, suppressing Paneth cell
differentiation and activating EGFR signaling. YAP and its associated transcriptional coactivator TAZ traditionally have been shown to link Hippo and Wnt-mediated signaling
cues to drive organ development, stem cell maturation and differentiation, and
oncogenesis [106, 107]. Interestingly, tumor cells can avoid chemotherapy-induced
apoptosis through increased Survivin expression, and this mechanism is dependent on
nuclear accumulation YAP [108]. This process is termed induced senescence, and may
relate to nutrient availability. Appropriately, recent data has implicated energy stress as a
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critical driver of YAP/TAZ activity [109], specifically the signaling program’s reliance on
aerobic glycolysis [110, 111]. Transcript data from the current studies reveals a
decrease in expression of enzymes correlating with increased glucose transport into
cells (Glut1) and catalytic conversion from glucose to glucose-6-P (HK2), suggesting
altered glucose transport and subsequent glycolysis (Fig. 2.3D). This should correlate
with decreased YAP/TAZ at baseline [109]. However, the metabolic shift occurring after
radiation injury was not investigated in the current studies, so it is possible that radiationtreated IECs undergo a shift from OXPHOS to aerobic glycolysis, as others have
reported [112] and YAP/TAZ subsequently regulates the cellular plasticity demonstrated
in our model. This pathway should be investigated in future studies.
Taken together, the data presented in the current study support the conclusion
that PI3K plays an essential role in priming the epithelial crypt against radiation damage.
This event appears to be dependent on enhanced OXPHOS driving Complex IIImediated ROS generation and p38-MAPK dependent differentiation pressure occurring
before injury stimulus. While diminished baseline ISCs may have detrimental affects on
resting crypt survival (Fig 2.5E), primed cells rapidly replenish the crypt ISCs after injury
stimulus. Given the importance of crypt restitution after radiation injury, a limiting factor
in the delivery of therapeutics for abdominal and pelvic malignancies [113, 114], further
investigation into the mechanisms elucidated here might develop into effective
therapeutics.
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Chapter 3: Glucocortioid Therapy Impairs ISC Activation Independently of
Inflammation to Prevent Mucosal Restitution in IBD
Introduction:
Inflammatory Bowel Disease (IBD) is a prevalent medical disorder carrying
significant health and economic burden. Recent reports predict that disease
pervasiveness will continue to grow exponentially due to compounding prevalence [115].
The permanence of current treatment strategies has also been called into question as no
approach has been proposed to combat the steady climb in worldwide disease burden.
IBD disease activity is characterized by epithelial ulceration in the face of overwhelming
inflammatory burden. Achievement of mucosal healing, or the re-establishment of an
epithelial monolayer separating the intestinal luminal contents from the lamina propria,
correlates with better long-term outcomes [116, 117]. Clinically, physicians focus on
inducing a state of remission by limiting peak inflammatory burden within the intestine,
and then switching the patient to a maintenance therapy to prevent future inflammatory
“flare-ups”. Glucocorticoid-induction therapies continue to be a mainstay of IBD
treatment for acute flares, despite reports of inconsistent endoscopic disease remission.
Historically, primary usage of corticosteroids only leads to mucosal healing in 29% of
treated patients [118, 119]. In addition to the 16% of UC patients who do not respond to
initial steroid therapy, 49% do not maintain remission by one year [53]. Given the
abundant case-report literature on delayed mucosal repair in steroid-treated colitis,
closer examination into the mechanism should both inform clinical decision-making in
these patients and identify areas to optimize current treatment.
At the level of the intestinal epithelial cell (IEC), several key signaling pathways
integrate inflammatory responses to drive both the injury process and mucosal healing.
The NFκB family of transcription factors balances potent pro-survival [51, 120, 121] and
pro-death [122, 123] stimuli in response to inflammatory insult. The activation of
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canonical NFκB pathway by pro-inflammatory cytokines or specific pattern-recognition
receptors (PRR) drives proteasomal degradation of cytoplasmic inhibitory proteins (IκB
family) and allows for translocation of p65 protein to the nucleus. The most critical
example of the dual protective and pro-death roles of NFκB is illustrated by TNF
Receptor activation—where NFκB directs context specific cues to drive either caspase
8-mediated apoptosis[124], or the expression of anti-apoptotic and anti-oxidant genes to
increase cell survival [125]. Our lab has extensively characterized the role of the
epithelial TNF receptor in the context of inflammatory bowel disease [126]. Specifically,
TNFR actively participates in ISC self-renewal by stimulating Wnt signaling, providing
context to the importance of inflammatory responses in triggering mucosal restitution.
While IECs routinely activate NFκB for homeostatic control of the microbial community
[127], evidence also directly implicates aberrant NFκB signaling in the initiation and
perpetuation of colitis [128, 129]. These tenants establish context-specific NFκB
activation as a critical determinant of epithelial cell responses in colitis.
While the NFκB-dependent mechanisms of cellular survival are often appreciated
in controlling inflammatory diseases, glucocorticoid-dependent transcriptional pathways
regulate cell fate decisions in their own right. Cortisol is the main glucocorticoid (GC)
steroid hormone produced in the human body, and its activity is tightly regulated by the
hypothalamic-pituitary-adrenal (HPA)-axis during an inflammation [130]. In addition to
HPA axis control of cortisol, GC concentrations within the local environment are
regulated by the 11-beta-hydroxysteroid dehydrogenase (11β-HSD) system [131] and
through targeted alterations in the GR configuration within the cell [132]. These
mechanisms have been postulated to drive steroid-resistance in IBD; however, a
mechanistic evaluation of these claims is lacking. Mechanistically, IECs bind GCs with
their cytosolic glucocorticoid receptors (GR), which leads to dissociation of inhibitory
heat-shock proteins from the receptor to allow for dimerization and translocation to the

55

nucleus [133]. Glucocorticoid response elements (GRE) resident within the promoter
nuclear DNA accept the ligand-bound receptor complex to drive context-dependent
transcription. For example, in response to GC administration, IECs upregulate
glucocorticoid-induced leucine zipper (GILZ), serum/glucocorticoid regulated kinase-1
(SGK-1) and Mitogen-activated protein kinase/phosphatase-1 (MKP-1), all of which have
been implicated in intestinal homeostasis and regulation of colitis extent [134, 135].
These findings expose a critical gap in the current understanding of steroid-biology in
IECs—can GR-mediated transcriptional events independently direct ISC vitality and
function? As such, the role of GR-mediated transcription intersecting with known
activators of ISC is the focus of the current studies.
Constant epithelial cell turnover plays an important role in the development and
maintenance of the intestinal barrier function [136]. In response to inflammatory mucosal
injury, ISCs direct the restoration of the epithelial monolayer [21, 66]. Our lab has played
a critical role in defining the signaling mechanisms which drive ISC activation—
specifically the role of inflammation in activation Wnt/β-catenin signaling [54, 62, 137]—
adding to the rich understanding of Wnt responsiveness. Positive indicators of Wnt
signaling include TNF-mediated, Akt-phosphorylated β-cateninSer552 (p-β-cateninSer552),
Axin2, c-myc and cyclinD1. We extensively studied the role of Wnt signaling in colonic
ulcer healing using mouse models of colitis and human tissue [62, 126]. Defining a
mechanism integrating the unique contributions of GR, NFκB and Wnt in ISC activation
required for mucosal healing in steroid-treated IBD will significantly enhance our
understanding of molecular mechanisms of perpetuating disease. To this end, we
hypothesize that GR activity directly regulates nuclear Wnt/β-catenin transcriptional
activation required for ISC activation in the re-epithelialization of ulcer surfaces.
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Methods:
IBD Patient Data. After obtaining informed consent, adult colon tissue samples were
isolated from patients presenting to the UK Chandler Hospital or Veterans Administration
Medical Center (VAMC) (Lexington, KY) for screening colonoscopy or flexible
sigmoidoscopy for new onset (untreated) colitis, or steroid-treated colitis (prednisone).
Mayo scoring guidelines were followed as described [138].The University of Kentucky’s
and VAMC Institutional Review Boards approved all tissue collection.

Animals. All studies were performed according to University of Kentucky Institutional
Animal Care and Use Committee protocols. 8-20 week old C57Bl/6 mice (Jackson Labs,
Bar Harbor, ME) were used for all experiments. Animals were kept under specific
pathogen free (SPF) conditions and allowed access to chow and water ad libitum. To
induce acute colitis, mice underwent 7 days of 2% (w/v) dextran sodium sulfate (DSS)
and then 7 days of normal, autoclaved drinking water. Mice were scored every other day
using an adjusted disease activity index (aDAI) as previously described [139]. To assess
the effects of steroid therapy on to ulcer healing, mice were given once daily IP
injections of Dex (1.05mg/kg/day) following the 7th day of DSS administration for 7 days
until the sacrifice on the 15th day from the start of the experiment. This is a concentration
similar to that used in the treatment of acute idiopathic colitis in humans. Animals were
euthanized by CO2 asphyxiation and cervical dislocation.

Histopathologic evaluation of intestinal tissue sections: Human mucosal biopsies or
entire length of mouse colon will be excised, placed into 10% neutral-buffered formalin,
before undergoing paraffin embedding for histologic processing. 7 micron sections were
stained with hematoxylin and eosin and inflammation extent scored based on the sum of
3 parameters: 1) Presence of infiltrating immune cells (0 to 3 – 0 being absent to 3 being
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severe), 2) localization of inflammatory infiltrates (0 to 3, 0 absent, 1 mucosa, 2
submucosa and 3 transmural) and 3) localization of ulceration (0 to 3, 0 absent, 1 rectum
only, 2 rectum and some distal colon, 3 all areas of colon). Ulcer lengths were summed
and divided by the total length of the colon to obtain the “extent of ulceration %”. In
mouse data, extent of re-epithelialization was determined by appreciating an epithelial
monolayer adjacent an identifiable ulcer. Presence of a marginal crypt was suggestive
but not necessarily confirmatory for a newly re-epithelialized surface.

Immunohistochemistry. Tissues were fixed in 10% neutral buffered formalin overnight,
processed through paraffin and sectioned at 7 µm before analysis. Antigen retrieval of
formalin-fixed paraffin sections used Target retrieval solution (Dako, Carpinteria, CA)
and a decloaking chamber (Biocare medical, Concord CA). Sections were incubated
overnight with anti-p-β-cateninSer552 (1:250, Generous gift of Linheng Li, Stowers
Institute). Sections were incubated with anti-rabbit HRP labeled polymer (Dako). Stained
slides were developed using 3,3’-diaminobenzidine tetrahydrochloride (Dako) and then
counterstained with hematoxylin.

Mouse and Human IEC Isolation. IEC were purified using whole from mouse or human
crypts in as previously described by this lab [62, 78] and adapted based on recent work
[79]. Briefly, lengthwise sections of intestine were washed in 4°C Ca2+- and Mg+-free
HBSS (CMF-HBSS). The tissue was transferred to CMF-HBSS containing 10 mM
dithiothreitol and 50 nM calyculin A and 250 µM EDTA (Calbiochem) for 15-30 minutes,
4°C. Tubes were shaken and then tissue was transferred to fresh tubes containing CMFHBSS with 1 mM EDTA, 4°C for 1 hour. Epithelial cells were then dislodged by vigorous
shaking. Large pieces of tissue were discarded. IECs were harvested by centrifugation
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at 500xg for 10 minutes. Cells were snap-frozen in liquid nitrogen and stored at –80°C
until use. From this point, purified IEC were utilized for nucleic acid or protein analysis

Protein Fractionation and Western Blotting. Frozen human or mouse IECs were thawed
on ice and passed through a 27-gauge needle in ice cold buffer (50 mmol/L Tris-HCl, pH
7.4, 100 mmol/L NaCl, and 0.01% digitonin) containing protease (Pierce, Rockford, IL)
and phosphatase inhibitor cocktails (Sigma). Subcellular fractionation, protein isolation
and western blotting analysis were performed as described [22, 86]. Briefly, cells were
incubated for 5 minutes and centrifuged to obtain the cytosolic fraction. The remaining
pellet was suspended in ice-cold buffer containing protease and phosphatase inhibitor
cocktails (50 mmol/L Tris-HCl, pH 7.4, 2% Triton X-100, and 100 mmol/L NaCl),
incubated for 30 minutes, and centrifuged to remove the membrane and organelles.
Finally, the nuclear extract was purified by resuspension of the pellet in ice-cold buffer,
including protease and phosphatase inhibitor cocktails (50 mmol/L Tris-HCl, pH 7.4, 100
mmol/L NaCl, 0.5% n-dodecyl-β-D-maltoside, 2.2 mmol/L MgCl, and Benzonase) for 30
minutes at room temperature before centrifugation. Next, the protein fractions were
separated by SDS-PAGE using precast gels (Bio-Rad, Hercules, CA) and transferred to
polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA) using a semidry
electrotransfer apparatus (Bio-Rad). The membranes were blocked with protein-free T20
blocking buffer (Pierce, Rockford, IL) for 1 hour and incubated with primary antibodies
specific for p-β-cateninSer552 (1:250, Cell Signaling, 5651), Axin2 (1:100, mouse: Santa
Cruz, sc-25302; human: Cell Signaling, 2151), p-p65Ser276 (1:250, Cell Signaling, 3037),
cyclinD1 (1:250, Cell Signaling, 92G2), lamin B1(1:1000, Cell Signaling, 13435) and βactin (1:10000, Sigma), followed by corresponding anti-mouse or anti-rabbit secondary
antibodies. Proteins were detected by chemiluminescence (West Pico or West Dura kits;
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Pierce). Western blots were performed on protein isolated from at least three
independent experiments.

ISC Spheroid Culture. Spheroid cultures derived from mouse and human ISCs have
been validated to model the adult gastrointestinal system [140-142]. After isolating
colonic crypts as described above, crypts were suspended in 3-dimensional matrix using
Matrigel (Corning, Tewksbury MA). Spheroid culture cells were maintained as enriched
stem and progenitor cells by culturing in L-WRN conditioned media [143, 144]. To select
and proliferate stem cell cultures, 10 µM Y-27632 (ROCK inhibitor; R&D Systems, Cat.#
1254) was added to the medium provided immediately upon passage. A brief
maintenance schedule for spheroids included: passaging into Matrigel on Day 0, L-WRN
conditioned medium was changed on Day 2-3, and spheroids were passaged again on
Day 4-6. For transcript analysis of spheroid cultures, total RNA was isolated from
cultured spheroids on Day 3 with conditioned L-WRN or L-WRN with the addition of
12nM (500 ng/mL) dexamethasone (Sigma Aldrich, St. Louis, MO) after passage
(steroid-treated ISCs).

Real-Time PCR. Total RNA was isolated from intestinal epithelial cells using the RNeasy
Mini Kit (Qiagen, Valencia, CA) and reverse transcribed using High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Real time PCR used
the ABI Step OnePlus real-time PCR system and Power SYBR green PCR master mix
(Applied Biosystems). Primers were designed by Primer Express software 3.0 (Applied
Biosystems) based on nucleotide sequences from the National Center for Biotechnology
Information data bank. For each sample, beta-actin and 18S were used as a pooled
internal reference. All assays were performed in triplicate and fold changes were
calculated using the ΔΔCT method.
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NCM Cell Culture and TCF/LEF Luciferase Assay. NCM460 cells derived from normal
human colon mucosa were purchased from INCELL Corporation, and cultured in M3:10
medium with 30% conditioned medium. Cells were treated overnight with 5.3 pM (1
ng/ml) of recombinant TNF, 20µM LiCl and/or 12 nM (500ng/mL) dexamethasone
(Sigma-Aldrich, St. Louis, MO) before analysis. RU-486 (Sigma-Aldrich, St. Louis, MO)
is a potent GR antagonist [145]. Dose-response curves were performed to identify
optimal treatment concentrations. To detect transcriptional activity of β-catenin, cells
stably infected with a lentiviral reporter construct containing the TCF/LEF luciferase
reporter were treated, and luminescence detected in a microplate reader.

Statistics. For all experiments, pairwise comparisons were made using a two-tailed
Student’s t-test. Multiple comparisons were made using a one-way ANOVA with a posthoc Holm-Sidak correction. p< 0.05 is considered significant.
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Results:
Given reports on delayed mucosal repair in steroid-treated colitis [146], we
examined the hypothesis that steroid therapy adversely affects Wnt-induced IEC
responses during ulcer healing. Mucosal biopsies were taken from the rectosigmoid
region of patients with active, untreated ulceration visiting the University of Kentucky
Chandler Hospital and Veterans Administration Medical Center (VAMC) Lexington GI
Endoscopy Service. Representative images of normal colon tissue vs. inflamed, active
colitis are shown in Figure 3.1A-B. Data in Figure 3.1C-D demonstrate that despite longterm application of high doses of GC prednisone (>20mg/day), patients do not
experience endoscopic improvement in their Mayo scoring disease activity index (2.7 ±
0.4 in untreated vs. 2.8 ± 0.5 in steroid-treated colitis) or histologic improvement in
epithelial inflammation. In Figure 3.1E, IECs from biopsy specimen were purified and
subjected to western blot (WB) analysis. Patients with active UC exhibit elevated levels
of activated p-β-cateninSer552, a marker for activated ISCs, whereas steroid-treated colitis
had reduced nuclear accumulation of p-β-cateninSer552 . Additionally, we saw increases in
protein content of cytoplasmic Axin2, a Wnt target gene associated with UC activity. In
contrast, we saw that steroid treatment reduced Axin2 protein levels suggesting a failure
to enact molecular mechanisms required to heal colitis. In line with the established
mechanism of prednisone abolishing NFκB signaling, we identified a reduction of nuclear
phosphorylated-p65Ser276 compared to active UC, despite equivalent levels of tissue
inflammation seen endoscopically and histologically (Fig. 3.1C-D).
Given the negative impact of GC on mucosal repair in UC, we interrogated the
mechanism of GC effects on IEC in murine models of colitis. Using the DSS-induced
model of murine colitis, we evaluated how dexamethasone (synthetic GC steroid)
therapy affected mucosal healing. Our treatment strategy is outlined in Figure 3.2A.
Adjusted disease activity indices (aDAI) (Figure 3.2B) demonstrated that both groups of
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mice experience similar rates of disease onset, but steroid-treated mice experience a
more rapid return to baseline than their untreated counterparts—indicating clinical
improvement. We then isolated the entire colon for IHC analysis at Day 15 following
DSS initiation and calculated the percentage of colon length that contained an active
ulcer (red) or areas that experienced re-epithelialization (yellow). Representative
histologic images from untreated and steroid treated mice are shown in Figure 3.2C-D.
Data in Figure 3.2E demonstrate that despite clinical improvements in weight loss and
fecal occult blood seen in 3.2B, steroid-treated mice have equivalent levels of ulceration
and re-epithelialization compared to untreated counterparts, suggesting no appreciable
improvement in mucosal healing. Thus, despite clinical improvements, the overall impact
of steroid treatment in DSS colitis at the IEC-level remains unclear.
Given human data that GCs impair ulcer healing, we focused on how GCs may
impact stem and progenitor cell pools within crypt units. Thus, we interrogated GCmediated p-β-catenin suppression in our mouse model. Using IHC, we examined the
nuclear localization of p-β-cateninSer552 along marginal crypts surrounded ulcer surfaces.
Figure 3.3A demonstrates representative histological samples for untreated and steroidtreated colitis animals. In Figure 3.3B, we demonstrate that steroid therapy generates a
>50% reduction in p-β-cateninSer552 nuclear localization, suggesting a critical depletion in
cells responsible for jump-starting crypt restitution. Next, we isolated IECs and subjected
them to WB analysis. In addition to decreases in positive indicators of Wnt signaling
(Axin2, cyclinD1), steroids directly decrease nuclear p-β-cateninSer552 levels in epithelial
cells, corroborating our observations in human tissues (Figure 3.1). Taken together,
these data suggest GCs suppress Wnt-driven activation of ISCs in marginal crypts
surrounding ulcers, a key element of epithelial restitution, as a mechanism for decreased
mucosal repair.
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With a critical depletion in p-β-cateninSer552+ cells within marginal crypts, we
surmised delayed mucosal healing with steroid-treatment stems from an inherent
functional compromise of ISCs. To this end, we interrogated the effects of GC
application on isolated intestinal stem cell cultures directly. Using previously validated
methods for intestinal spheroid culture, we propagated ISCs from mice in culture. We
then subjected the cells to 12nM dexamethasone (500 ng per mL of L-WRN culture
media) and evaluated changed in culture characteristics. Particularly, we were interested
in how steroids affected Wnt-responsive elements (Lgr5, Axin2, c-myc), quiescent stem
and progenitor cell transcripts (Sox9, Bmi1, Lrig, mTert), transcripts associated with
epithelial differentiation (Tff3, ChgA, Muc2, CD44), transcripts associated with
proliferation, migration and epithelial to mesenchymal transition (Snai1, Slug, Ki67,
PCNA) and finally steroid response elements (SGK1, GILZ). Figure 3.4A illustrates the
volcano plot evaluating the differences between steroid-treated spheroid cultures and
control spheroids, and the statistical significance of those differences. Importantly,
steroid therapy increases transcripts associated with EMT and migration (Snai1) without
appreciable changes in proliferation (Ki67, PCNA). Further markers of high cycling stem
cells (Lgr5) are diminished in favor of Notch target and quiescent cell marker Sox9,
suggesting the consequence of decreased Akt-activated ISCs in margin crypts (Figure
3.3) results in the recruitment of reserve IEC populations to enact mucosal healing.
Given our data implicating GCs in directly impairing Wnt signaling, we sought to
interrogate the direct transcriptional effect of GCs on Wnt signaling with nontransformed
IECs transfected with a β-catenin reporter construct. Using NCM460 cells transfected
with a TCF/LEF luciferase reporter, we directly evaluated transcriptional alteration in βcatenin activation with GC administration, and concurrent administration of GC-specific
inhibitors. Using two different mechanisms, GSK3β inhibition (indirect Wnt activation) via
LiCl (20 µM) and inflammatory stimulus via TNF (5.3 pM), we stimulated β-catenin
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signaling in the transfected NCM460 cells. In agreement with our mouse data, the
addition of dexamethasone (12 nM) ablated the increase in Wnt signaling seen by either
stimulus (Figure 3.5A), suggesting that Wnt signaling interruption occurs downstream of
the GSK3β-dependent β-catenin destruction complex (mechanism of LiCl Wnt
activation). To interrogate the specificity of GC signaling, we employed the GR
antagonist RU-486. Data in Figure 3.5B similarly illustrate that addition of LiCl causes a
dramatic increase in TCF/LEF transcriptional activation, which can be appropriately
ablated by the addition of 12nM dexamethasone to culture. Impressively, Wnt repression
was rescued by GR antagonism in a dose-dependent manner. Specifically, the addition
of 5µM of RU-486 returns TCF/LEF activation to baseline levels of LiCl stimulated NCM
cells in the presence of 12nM dexamethasone, suggesting receptor antagonism is
sufficient to block GC-mediated effects on active Wnt signaling.
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Chapter 3 Figures:
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Figure 3.1: High-dose Steroid Therapy Limits Wnt and NFκB signaling in IECs, but
not Tissue-level Indicators of Inflammatory Damage in IBD. Patients presented to
the UK Chandler or Good Samaritan Hospitals at the University of Kentucky for
diagnosis or surveillance of untreated or steroid-treated colitis. Representative
endoscopic images of normal (A) or actively-inflamed (B) colon tissue. (C) Mayo scoring
and (D) histologic evaluation of mucosal biopsies reveal steroid therapy, despite
promoting clinical improvement, does not appropriately reduce endoscopic or histologic
indicators of inflammatory damage. (E) WB analysis of isolated IECs reveal steroids limit
positive indicators of Wnt/β-catenin signaling and NFκB signaling.
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Figure 3.2: Despite Clinical Improvement, Steroid-Therapy Does Not Improve
Mucosal Healing in DSS Model of Murine Colitis. Wild-type C57Bl/6 mice were
treated with 7 days of 2% DSS w/v and then 7 days of autoclaved water or once daily
intraperitoneal injection of 1.05 mg/kg dexamethasone (A). Adjusted Disease Activity
Index (aDAI) integrating clinical observations in weight change and fecal occult blood (B)
revealed improvement at day 11-13 in steroid treated mice. Histological examination of
colon tissue in DSS-only (C) and DSS + Dexamethasone therapy (D) and evaluation of
aggregate levels of tissue ulceration and re-epithelialization (E) revealed no differences
between the two groups. Red (ulcer), Yellow (re-epithelialized tissue), *p<0.05. Values
representative of means ± SEM
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Figure 3.3: Steroid-treated Colitis Limits Wnt/β-catenin Signaling and p-βcateninSer552+ cells in marginal crypts. Representative histological sections of murine
marginal crypts bookending ulcerated or re-epithelialized tissues in DSS-only (A) or
steroid-treated DSS colitis (B) stained for TNF-mediated, Akt-activated p-β-cateninSer552.
p-β-cateninSer552 counts per marginal crypts (C) revealed a greater than 50% decrease in
positive cells. WB analysis (D) from mouse IECs revealed decreases in inflammatory
mediated Wnt signaling stimulus with steroid therapy, although this decrease was not
dependent on immune stimulus. Arrows = pBcat+ cell. Values mean ± sem, *p<0.05.
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Figure 3.4: Dexamethasone Treatment Suppresses Active ISC Signatures in
Spheroid Culture. Murine crypts were isolated and passaged within L-WRN conditioned
media to create spheroid cultures. (A) Volcano plot demonstrating multiple t-tests for
significantly increased (blue) transcripts in dexamethasone-treated spheroid cultures,
which include glucocorticoid responsive transcripts SGK1, GILZ; quiescent transcript
Sox9 and EMT response element Snai1, at the expense of active cycling ISC transcript
Lgr5. Representative pictures of untreated (B) and steroid-treated cultures (C).
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Figure 3.5: Steroid-mediated Blunting of β-catenin Transcriptional Activity can be
Rescued by GR Blockade. NCM460 non-transformed colonic epithelial cells were
stably transfected with a luciferase reporter for β-catenin transcriptional activity. (A)
TCF/LEF luciferase activity measured in relative fluorescence units (RFU) in NCM460
cells. Stimulation with 20µM LiCl (a GSK3β inhibitor), or 5.3 pM (1 ng/mL) TNF
(inflammatory stimulus) overnight. Cells then received either no additional treatment, or
pre-treatement with 12 nM (500 ng/mL) dexamethasone (Dexa). Steroids reduce βcatenin activity downstream of the destruction complex. (B) TCF/LEF luciferase in
NCM460s with the addition of RU-486, a GR-antagonist, rescues β-catenin stimulation.
Values mean ± sem. *p<0.05 to control, **p<0.05 to TNF, uup<0.05 to LiCl.
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Focused Discussion
Data shown in the current studies reveal steroids directly impair ISC activation
required to enact mucosal restitution in IBD. Further, the mechanism occurs
independently of inflammation-induced ISC activation; suggesting prolonged supertherapeutic doses in IBD may have downstream effects on ISC function and delay ulcer
healing. Our specific investigation into GR-dependent suppression of mucosal restitution
was initiated after the observation that steroid-treated IBD patients have decreased ulcer
healing (impaired Wnt-responsiveness in IECs) over untreated counterparts, despite
equivalent levels of inflammation—underscoring the clinical significance of our findings.
Experiments performed here not only outlined both the critical interaction between GR
and Wnt signaling pathways, but also localized the level of intervention downstream of
the cytosolic β-catenin destruction complex. In ISC culture, this novel signaling
interaction triggers as the shutdown of high-cycling stem cell transcriptional programs
(Lgr5) and require the activation of reserve cell types (Sox9). Decreased activated stem
programs limit the number of Wnt-responsive cells in marginal crypts required to heal
tissue ulceration in mouse, and subsequently, human colitis. Evidence presented within
this chapter, specifically the transcriptional reversibility of GR-mediated Wnt antagonism,
highlights potential therapeutic interactions that may improve mucosal healing with future
investigation.
Our data present a novel role of GCs on ISC self-renewal and maintenance.
Results from the current studies indicate that dexamethasone administration has the
ability to limit β-catenin activation through NFκB-dependent inflammatory signaling (TNFmediated), as well as downstream inhibition of GSK3β-mediated β-catenin destruction
(LiCl-mediated). These findings make a potential nuclear-based mechanism an attractive
candidate, specifically through the direct interaction of ligand-engaged GR with β-catenin
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or other transcriptional co-activators. To this end, Schwitalla and colleageus implicated
NFκB in directly regulating nuclear β-catenin levels through their shared coactivator,
CREB-binding protein (CBP). With constitutive activation of NFκB, CBP is required for
increased nuclear β-catenin [147]. We suspect that dual activation of p65/RelA and GR
causes competition for this co-activator and the competition lessens the desired effect
on Wnt/β-catenin signaling [148], leading to decreased stem cell activation and delayed
mucosal healing. Thus, further investigations into the interactions of ligand-engaged GR
receptor with nuclear co-activators, like CBP, within ISCs may yield a clearer
mechanistic understanding of Wnt-repression and decreased ISC activation.
Data from spheroid cultures revealed that GC-mediated Wnt suppression
decreases Lgr5 transcripts requiring the activation of reserve population transcripts
(Sox9+) and the EMT marker Snai1, in addition to the increase in CD44. Work from the
Magness group has established Sox9 as a critical component of “reserve stem” and
secretory progenitor cell populations [149, 150]. Specifically, activation of Sox9 indicates
cell populations primed to respond to injury mechanisms that attack high-cycling stems,
including radiation [5]. CD44, a typically Wnt-responsive gene indicating stem and
proliferative progenitors, paradoxically showed increases within our dexamethasonetreated spheroid system. While the high levels of natural CD44 ligand hyaluronan in
Matrigel may explain the increase in signal, the concomitant increase with EMT-marker
Snai1 might highlight an underappreciated role of CD44-related signaling in our
experiments. In cancer literature, CD44 signaling regulates the progression and
metastasis of cancer cells through its dynamic regulation of the actin cytoskeleton [151,
152]. Elevations in migration and EMT signatures may indicate the excursion from the
proliferative ISC niche to a less Wnt-responsive, more terminally differentiated region of
the crypt unit—as spatial distribution within the crypt belies Wnt sensitivity. These
findings would directly contradict findings in airway epithelial cells, where
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dexamethasone directly inhibits TGF-β1-mediated epithelial to mesenchymal transition
via the downregulation of Snai1, and our own observations on GC-specific effects on
migration potential of Caco2 cells (data not shown). Our data expose lineage-specific,
context-dependent GC effects on epithelial cells, and should not apply universally across
all epithelial cell types.
An equally important finding within our ISC culture system was GC-mediated Wnt
suppression in ISCs despite the optimal concentrations of Wnt ligands. The culture
system utilized in the current studies models the procedures outlined by the
Stappenbeck lab [143], where ISC “spheroids” are produced from isolated crypts,
suspended in 3D matrix (Matrigel) and maintained with conditioned media. The
conditioned media, obtained from a specific cell line producing all or some of the 3
protein components—Wnt3a, R-Spondin and Noggin—is essential for promoting ISC
self-renewal properties [141, 144]. While some have theorized that there may be batchto-batch variability in conditioned media, previous research has shown that under almost
every circumstance without obvious technical errors, L-WRN conditioned media batches
produce identical ISC self-renewal capabilities [144]. Thus, our finding that
dexamethasone-treated ISC cultures suppress self-renewal programs and alter spheroid
morphology despite equivalent levels of essential protein components (Wnt ligands) is a
novel discovery. Interestingly, Yan and colleagues recently demonstrated the nonequivalence of both Wnt and R-spondin in driving ISC self-renewal [28], specifically
highlighting how Wnt ligands themselves are insufficient to maintain ISCs. Rather, Wnt
activation allows for the maintenance of R-Spondin receptor (Lgr4-6, ZNRF3, RNF43)
expression [28], suggesting the ligands act independently to regulate ISC priming and
propagation for tissue regeneration. While we theorize our data expose a complex
relationship between GCs and Wnt signaling required for maintenance of high-cycling
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stem cells, we cannot rule out the possibility that dexamethasone alters ligand
bioavailability within the culture system, causing the altered ISC characteristics.
Some investigators have concluded that a distorted ability to recruit immune
constituents (macrophages, neutrophils) is the primary failure with steroid therapy [153].
However, the clinical utilization of these data in treating IBD is limited, as histologic
changes in colitis patients indicate chronic dysregulation of immune components exist
before steroid-intervention and persist even in individuals who achieve mucosal healing.
These observations underscore two possible outcomes: genetic factors that predispose
patients to different classes (high-responders, low responders/steroid refractory patients)
or the precise time-dependent regulation of the inflammatory stimulus may be essential
to mucosal healing. The significance of time-dependent cellular responses in GC therapy
stems from two important studies: 1) Florian Greten’s work demonstrating NFκB in
epithelial cells is essential for mucosal restitution in animal models of colitis [154, 155]
and 2) Michael Karin’s work demonstrating the inhibition of NFκB in epithelial cells in the
setting of chronic inflammation prevents transformation to colitis-associated cancer [156,
157]. Activation of receptors upstream of compromised NFκB signaling leads to
significant pro-death signals in epithelial cells. However, perturbations in NFκB signaling
will depend on the timing of steroid dosing, duration of treatment, local drug levels and
the cell type affected, suggesting that there exists a critical window between the
beneficial and detrimental effects of steroid therapy. Our time-dependent steroid
administration in DSS-colitis mice revealed significant improvement in clinical indicators
of colitis severity without concomitant improvements in ulcer healing. In steroid-treated
patients, clinical data have shown a consistent improvement in disease symptoms
(decreased abdominal pain, decreased rectal bleeding, decreased stool frequency),
while ulcer healing is significantly delayed [158]. Under circumstances where steroidtreated patients do achieve mucosal restitution, >40% do not maintain remission 1 year
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after treatment completion, necessitating a switch to biological therapies. These
observations suggest that by the time GCs have been administered, the inflammatory
stimulus has evolved beyond the capacity of GR-mediated anti-inflammatory
mechanisms to induce appropriate epithelial cell responses. Thus, we posit the finding
that GCs can impair ISC activation irrespective of inflammatory stimulus becomes even
more meaningful as GCs ability to combat inflammation wanes. Taken together, our data
support a critical inhibitory role of GR-signaling on ISC responses to injury in a clinically
relevant manner, and this interaction is reversible with GR-specific antagonists. Future
investigation into time-dependent, and patient specific GC responses might reveal
regulation on complex gene networks in IBD responses and elaborate new treatment
strategies for the management of acute and chronic colitis.
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Chapter 4: Overall Conclusions, Limitations and Future Directions
Intestinal crypts demonstrate remarkable regenerative capacity in the face of
tissue injury. Lgr5+ stem cells primarily drive crypt restitution [2]; however, their absence
does not compromise mucosal healing [50]. Despite the dispensability of Lgr5+ cells in
initiating the healing response, evidence has shown that re-establishment of crypt
homeostasis depends on the ability to regenerate new Lgr5+ ISCs after injury [63].
Whether initial ISC injury directly activates a “reserve” stem cell population [159] or
causes the activation of de-differentation paradigms [11] in progenitor cells remains the
topic of considerable debate [160]. However, the current thesis endeavored to establish
context-dependent mechanisms driving interconversion of ISCs and committed
progenitors regardless of mode of injury. Our work focused on the critical signaling
pathways regulating maintenance of ISCs—Wnt and PI3K. Our research suggests ISC
integrate a network of cell-intrinsic and local microenvironment factors to determine the
optimal balance between active self-renewal and passive maturation. We have proposed
a model at the end of the chapter. The current studies add to the understanding that
metabolic shifts in IECs drive differentiation responses [43, 49] and that consistent Wnt
stimulus is insufficient to independently drive ISC self-renewal paradigms [28]. Further,
our work investigates two clinically relevant injury circumstances, IBD and radiationinduced enteritis, and provides mechanistic context to patient treatment failure which
should be used to design future therapeutic alternatives. A closer consideration of three
key findings of our work will inform the future directions of the current research.
Our work adds to the current understanding that ISCs integrate context specific
signals from their local environment to drive maintenance and self-renewal capacity [74,
160]. When the inputs into this tightly regulated network change—including altered
nutrient availability or change in the composition of mesenchymal, stromal or microbial
constituents—ISCs exhibit dynamic flexibility in their responses. However, their plasticity
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in both identity and activity underpins how dissimilar environmental changes can have
overlapping consequences. Data presented in this thesis reveal that enhanced OXPHOS
in IECs promotes increased mitochondrial ROS production. We theorize metabolic
alteration results from a cell-intrinsic change (enhanced PI3K) as suggested in other cell
types [161]. However, additional evidence presented in this thesis revealed a dramatic
change in both the composition of the microbiome (increased Lactobacillus spp.) and
crypt niche (increased Paneth cell size, number)—suggesting the genetically altered
crypt establishes new homeostasis. Dynamic alteration of epithelial-stromal-immune
symbiosis has previously been reported in carcinogenesis [162], where cancer stem cell
responses were found to depend more on their local environment than their genetic
hardwiring. However, similar studies in normal, nonmalignant IECs are conflicting,
qualitative or rely heavily on genetic manipulation of known cell markers [163]. With this
in mind, a closer investigation of the new normal environment in our p85ΔIEC crypts is
warranted in future studies.
Evidence within Chapter 2 suggests that p85ΔIEC crypts reduce the number of
functional Lgr5+ cells, and increase the proliferative progenitor compartment.
Appropriately, decreased high cycling stems within the crypt niche resulted in increased
Paneth cell size and number. Transcript analysis presented in Chapter 2 suggest that
this occurs as a result of diminished Notch activation, which plays both an essential role
in the maintenance of Lgr5+ stems [164] and the size of the secretory progenitor cell
pool [32]. However, the loss of Lgr5+ in p85ΔIEC mice was accompanied with a decrease
in crypt survival under homeostatic conditions, as compared to their WT counterparts. In
a sense, basal signaling in p85-deficient crypts increases ISC cellular stress more than
WT mice. In this context, the role of Paneth cells shifts should shift from ISC support
[165] to an active contributor to the healing response. The accelerated response of
p85ΔIEC mice to radiation injury, as seen in Chapter 2, could result from our expanded,
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radioresistant [166] Paneth cell pool undergoing dedifferentiation. Our ISH results not
only show definitive recovery of Lgr5+ ISCs after radiation injury but also accelerated
recovery in p85ΔIEC vs. controls; thus, identifying the cell-type responsible would increase
the impact of the current work. In a recent investigation, Jones and colleagues
investigated post-mitotic Defa4Cre Paneth cells’ capacity to dedifferentiate through the
targeted activation of Notch after doxorubicin injury [167]. Doxorubicin injury was
preferred due to its specificity for high-cycling cells, while sparing other lineages,
including Paneth cells. Lineage tracing experiments revealed that Notch activation
indeed generated functional, multipotent progenitors from Def4a+ Paneth cells, and the
genetic deletion of the essential Notch signaling alpha-secretase Adam10 [164]
mitigated the regenerative capacity of these cells. Indeed, previous work has illustrated
the indispensible role active Notch signaling plays in the responsiveness of crypts to
radiation injury [75, 168]. Further, Notch activation is sensitive to ROS signaling [169]
and integrates environmental signals from Lactobacillus spp. [170]. With this in mind,
directly interrogating Notch’s role in driving Paneth cell dedifferentiation after radiation
injury in our current model might clarify the mechanistic basis for our current
observations.
A second major finding from the current work included the discovery that IEC
mitochondria drive metabolic programs within IECs that trigger cell fate decisions. Using
Seahorse bionanalysis, evidence presented in Chapter 2 demonstrated that constitutive
activation of PI3K led to enhanced OXPHOS at baseline in IECs. The elevated OXPHOS
reliably activated p38 MAPK, as seen by other investigators in culture [49], which has
been shown to drive differentiation responses. These observations correlated with our
increased progenitor cell pool and diminished ISCs population seen at baseline in PI3K
enhanced mice. Despite focused studies to target the source of increased ROS
(Complex III), a limitation of the current studies is the absence of a direct mechanism
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linking mitochondrial-derived ROS with differentiation. Said differently, we definitively
see increased mitochondrial-derived ROS, and show data demonstrating ROS reliably
activates p38-MAPK, but mechanistic studies linking these two observations are lacking.
If ROS signaling is indeed required for PI3K-mediated differentiation pressure in IECs,
then isolated ISCs from p85ΔIEC should be sensitive to antioxidant treatment, or specific
mitochondrial ROS inhibitors (MitoQ) in culture. Further, normal ISCs should be
triggered to maintain self-renewal or differentiate based on compounds that either
enhance or diminish OXPHOS activity to titrate endogenous ROS. The therapeutic
implications of this discovery would be substantial. In both inflammatory bowel disease
[171, 172] and radiation induced enteritis [173], mitochondrial damage and loss shifts the
crypt metabolism to a glycolytic phenotype. The idea that injured crypts could be primed
to optimize crypt regeneration before receiving an injury stimulus would revolutionize
radiation-based therapies for abdominal and pelvic cancers, where maximum dosages
are limited by GI side effects. Thus, the current studies offer both firm evidence
corroborating metabolic shifts affect IEC fate decisions, and an opportunity for future
investigation to establish the metabolic requirements of optimal healing responses in
patients.
Metabolic shifts in IECs may also control phase changes in epithelial responses
to wound healing of the intestine. Miyoshi and colleagues demonstrated that a transient,
multipotent wound-associated epithelial (WAE) cell is required to heal ulcers [174].
These WAEs arise from marginal crypt structures surrounding ulcerated tissues [143],
and Seahorse bioanalysis revealed these WAEs depend on enhanced OXPHOS for
optimal function [175]. These data gave context to clinical observations in Crohn’s
Disease patients, which indicate diminished mitochondrial function in IECs impairs ulcer
healing in CD patients [176, 177]. Interestingly, these authors also show WAE initiation
depends on maintained nuclear β-catenin [175], suggesting that the p-β-catenin+ cells

84

seen in Chapter 3 could generate WAEs. With this in mind, the complex GC-mediated
decrease in activation nuclear of β-catenin would functionally reduce the number of
active WAEs present to heal ulcer tissues, suggesting a direct mechanism of delayed
ulcer healing. However, a well-designed examination of steroid effects on WAEs would
be needed. Miyoshi and colleagues demonstrated that these cells form when a
prostaglandin-E2 (PGE2) engages its EP4 (PTGER4) receptor, as pharmacologic
inhibition or genetic manipulation of the E4 receptor limited the number of WAEs in vitro
and in vivo and caused impaired epithelial restitution. This mechanism contrasts the
well-established PGE2-EP2 mechanisms guiding ISC survival in response to radiation
injury [178]. However, the combined studies provide credence to the notion that PGE2directed signaling mechanisms have important consequences on mucosal restitution
after injury. Glucocorticoids target COX-2 upstream of PGE2 to limit production [179,
180], but the clinical relevance of these mechanisms may depend on prior therapies
[181] and do not consider PGE2-promoting metabolites (deoxycholate) produced from
microbiota [182]. In human disease, PGE2 has a complex relationship during the healing
response in IBD [183]. Indeed, PGE2 is required for murine WAE as discussed, and
inhibition of PGE2 activity in myofibroblasts increases susceptibility to DSS-colitis [184],
but increased PGE2 reliably predicts which patients will have impaired mucosal
restitution and become refractory to anti-TNF treatment [185, 186]. This argues that the
best approach to understanding the clinically relevant GC-mediated effects on ulcer
healing in IBD would be captured with a prospective clinical trial (untreated vs. steroid
treated), where treatment-specific effects on human disease could be isolated.
An unexpected finding from Chapter 3 was histologic evidence of crypt fissioning
in our DSS-induced colitis model. Crypt fissioning, or the ordered bifurcation of an entire
crypt into a two daughter crypts, is responsible for increasing crypt number in post-natal
intestinal tissues [187, 188]. Under homeostatic conditions, the amount of crypt
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fissioning events is equally balanced by crypt fusion events [189], to keep the number of
crypts approximately constant. However, under injury circumstance, specifically in
response to radiation [190] or inflammatory bowel [191], crypt fissioning processes
dominate fusioning, and are required to generate new crypt structures during healing. In
collaboration with Linheng Li, our laboratory helped establish that enhanced PI3K
(through the deletion of PTEN) increased crypt fissioning in mice [40]. Evidence
presented in those studies revealed p-β-catenin+ cells within marginal crypts
represented points of eventual bifurcation of crypt structures for the initiation of
fissioning. Interestingly, data presented in this thesis demonstrate a statistically
significant decrease in Akt-phosphorylated β-catenin+ cells in marginal crypts at Day 15
in steroid treated mice, which might suggest a mechanism for treatment failure in
steroid-treated IBD would be inadequate ability to induce crypt fissioning. However,
further study is required.
Of note, our previous work indicated initiation of crypt fissioning required Aktmediated activation of β-catenin [40]. In our p85ΔIEC mice, p-Akt and p-β-cateninSer552 are
both increased, however baseline crypt survival decreases—suggesting a more complex
mechanism occurring during homeostasis. Evidence from intravital imaging and
mathematical modeling has confirmed that crypt fissioning events are approximately
balanced with fusion and death events in homeostasis, as discussed [188, 189].
However, these models surmise that a) stem cells numbers are small and consistent
throughout the crypt and b) stem cells are equally segregated between fissioning
groups. Our suggest neither are true in our model. As fissioning events ramp up through
the constitutive activation of Akt phosphorylation of β-catenin (increased by WB), and the
number of stem cells per crypt decrease (decreased by ISH) these assumptions fail,
causing insufficient or absent stem populations to support crypt function, and explaining
impaired crypt survival at baseline in our model.
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Summary and Model
Data in this thesis add to the rich literature demonstrating ISCs integrate cellintrinsic and environmental stimuli (exogenous therapies) to drive maintenance and selfrenewal. The current model summarizes these inputs. Wnt/β-catenin is considered the
master regulator of ISC proliferative and self-renewal capacity. Wnt/β-catenin ligands
can come from mesenchymal tissues, but epithelial can be activated by intrinsic NFκB
signaling through TNF-stimulation or interaction with the microbiome. Ligand engagedGCs can limit inflammatory activation of Wnt/β-catenin, while having independent
interactions with β-catenin within the nucleus absent inflammatory stimulus. PI3K can
independently activate Wnt/β-catenin while also playing a significant role on metabolic
programs to indirectly increase OXPHOS. Importantly, commensals within the
microenvironment, adjacent cells (Paneth) and metabolism interregulate each other. As
OXPHOS increases, mitochondrial-derived ROS increases can subsequently activate
p38-MAPK. MAPK prevents ISC maintenance and self-renewal, instead favoring exit
from the niche and differentiation. Green: Activation; Red: Repression; Grey: Proposed
interactions in literature not directly investigated by the current studies
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β-catenin

BMP

Bone Morphogenic Protein

DAI

Disease Activity Index

Dexa

Dexamethasone

DSS

Dextran Sodium Sulfate

ETC

Electron Transport Chain
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Glucocorticoid

GR

Glucocorticoid Receptor

GRE

Glucorticoid Response Element

GSK

Glycogen Synthase Kinase

HPA

Hypothalamic-Pituitary Axis
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Inflammatory Bowel Disease

IEC

Intestinal Epithelial Cell

IHC

Immunhistochemistry

ISC

Intestinal Stem Cell

LiCl

Lithium Chloride

NFkB

Nuclear Factor Kappa B

OXPHOS

Oxidative Phosphorylation

p-

phosphorylated-

p85

ΔIEC

p85-deficient Intestinal Epithelial Cell

PCR

Polymerase Chain Reaction

PI3K

Phosphatidyl-Inositol 3 Kinase

PKB

Protein Kinase B

q-ISC

Quiescent Intestinal Stem Cell

SI

Small Intestine

Spp.

Species Pluralis

WB

Western Blot

WBR

Whole Body Irradation
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